2008-2009 Annual Report: "Envisioning Tomorrow's Innovations... "

The Ruth J. & Maxwell Hauser and Harriet & Arthur H. Aufses, Jr., M.D.
Department of Surgery
2008-2009 Annual Report
envisioning tomorrows innovations...
The Mount Sinai Surgery Advisory Board

Michael L. Marin, M.D. Chairman, Department of Surgery The Mount Sinai Medical Center David S. Blitzer Senior Managing Director Corporate Private Equity Group The Blackstone Group Magnus Bcker President NASDAQ OMX Group Inc. Grahame Chilton Vice Chairman Aon Group Scott D. Flora President, Surgical Devices Covidien Antonietta G. Lauto Private Investor John J. Lauto Chief Executive Officer Spear, Leeds and Kellogg Managing Director Goldman Sachs & Company Ira A. Lipman Founder and Chairman Guardsmark, LLC Robert Ira Sahn Commodities Trader Kenneth Silverman Chairman and CEO The Silverman Group Barry Weiss Chairman and Chief Executive Officer, RCA/JIVE Label Group A Division of Sony Music Entertainment The Mount Sinai Surgery Advisory Board is a dynamic group of dedicated supporters who have joined our world renowned surgeons, to continue the mission of sustained excellence and innovation in the field of surgery. The Advisory Board is briefed firsthand by our leading Department of Surgery clinicians, scientists and educators on the latest medical advancements in cutting-edge technologies, research and surgical treatments. The Department looks to the Advisory Board members for their extensive expertise, business acumen, analytical skills and knowledge of corporations. This partnership offers Mount Sinai the ability to ensure future generations of surgical advancements will develop and be implemented. For further information about The Mount Sinai Surgery Advisory Board, The Friends of The Mount Sinai Department of Surgery and other involvement and philanthropic opportunities, please contact: Randy Wellner Director of Development Department of Surgery The Mount Sinai Medical Center 212-659-1592 randy.wellner@mountsinai.org
Table of Contents
Letter from the Chairman Historical Perspective Clinical Operations Whats New Surgical Innovations Global Initiative Research Education and Residency Division of Colon and Rectal Surgery Division of General Surgery Division of Laparoscopic and Minimally Invasive Surgery Division of Organ Transplantation Division of Pediatric Surgery Division of Plastic and Reconstructive Surgery Division of Surgical Intensive Care Division of Surgical Oncology Division of Vascular Surgery Administrative Governance Philanthropy 2008 Publications 1 2 4 6 8 10 12 13 14 15 16 17 18 19 20 21 22 23 24 25
The Ruth J. & Maxwell Hauser and Harriet & Arthur H. Aufses, Jr., M.D. Department of Surgery
5 East 98th Street, Box 1259 New York, N.Y. 10029 www.mountsinai.org/surgery
Letter from the Chairman
Michael L. Marin, M.D., F.A.C.S. The Julius H. Jacobson II, M.D., Professor of Surgery Chairman, Department of Surgery Mount Sinai School of Medicine
Welcome to the Department of Surgery at The Mount Sinai Medical Center. I am extremely pleased to present our 2009 annual report. Over the past year, our Department has experienced unprecedented growth across all of our various clinical, research, and education programs. We have seen significant growth in faculty, hospital discharges, research programs and in both clinical and research revenues. This report will provide a glimpse of the various aspects of expansion within our world renowned Department of Surgery. Several of these key areas include: This year the Department has added six new faculty members. The creation of a new Department of Surgery Melanoma Program, with enhanced treatments of this common and deadly disease using immunotherapy protocols. Our Center for the Surgical Treatment of Liver Cancer (the largest program in the country) offers many patients hope for a cure. Introduction of our new state of the art practice office suites. Each suite is uniquely designed for a surgical specialty and targets patients needs. Opening of the new Department of Surgery Conference Center. This technologically advanced conference room allows for complete interactive OR training sessions, and live video conferencing. Installation of the Storz OR minimally invasive operating rooms. This high tech system allows for state-of-the-art imaging and interactive training sessions during surgery. Establishment of a Department of Surgery Advisory Board and development of a Friends of Surgery Group which builds a critically important connection with our donors and contributors within our Department. Continued dedication and expansion of our Department of Surgerys Global Health Program. Through ongoing sponsorship we have been able to send our faculty and students to the Dominican Republic, Vietnam, Peru and other international locations to provide much needed medical care and training. It is through these highlighted areas and many more that enable our Department of Surgery to be at the leading edge in patient care, education, and research. As the Chair of this Department, I am exceedingly proud of our continued growth and sustained excellence. I invite you to see for yourself what makes Mount Sinais Department of Surgery so special. Exceptional programs. Exceptional leaders. Exceptional surgical care.
HISTORICAL PERSPECTIVE
The Mount Sinai Hospital admitted its first patient on June 8, 1855 just three days after opening its doors where the attending, Dr. Israel Moses, successfully operated on a 42 year old male. The patient returned home five days later in good condition. Since then, the Department of Surgery has played a key role in the institutions evolution and success. Excellence in patient care and physician education has distinguished Mount Sinai from its competition throughout its 150-plus-year history - long before the young Mount Sinai School of Medicine received its state charter in 1963. From its original 45-bed building, The Mount Sinai Hospital served New York City during tumultuous periods including the Civil War years, the Draft Riots of 1863 and the Orangemen Riots of 1871. In 1872, the move to larger quarters on Lexington Avenue coincided with the formation of The Mount Sinai Medical Board. Mount Sinai has gone through numerous changes over the years. By 1904, when the hospital moved to its current site on the Upper East Side, the growth of the Department of Surgery and the surgical specialties required reorganization yet again. Ten years later, the surgical service split into four separate divisions: thoracic surgery, neurosurgery, genitourinary service and intestinal service. With this evolution, Mount Sinai became an early leader in surgical specialization. Many Department members have revolutionized the practice of surgery, beginning with Dr. Arpad Gerster, Chief of Surgery at Mount Sinai from 1882 to 1914. Dr. Gerster published The Rules of Aseptic and Antiseptic Surgery in 1888. This groundbreaking book played a key role in spreading the concepts introduced by Lord Joseph Lister. Notable achievements by The Mount Sinai Department of Surgery members include:
The Mount Sinai Hospital 1855
Led by Dr. Marin, who became Chairman in 2003, the Department of Surgery now includes nine divisions, with 132 faculty members and 73 residents. All of these men and women continue to build on the Departments rich heritage, setting new standards in patient care, clinical research and physician education.
Dr. George Brewer, a genitourinary specialist who became famous for his description of Brewers Kidney, joined the House Staff in 1899 in which he took asepsis one step further by introducing rubber gloves in the operating room. The pristine white coat, another symbol of sterility and cleanliness was introduced by Dr. Southgate Leigh. Dr. Howard Lilienthal, developed many important inventions including a portable operating table that served as the precursor for the field operating tables used in World War I. He was also the surgeon of record who operated on the first U.S. patient to receive a blood transfusion using a solution developed by Dr. Richard Lewisohn, another member of our department. The discovery of general anesthesia used in the world today was introduced by Dr. Charles Elsberg in 1910, who later became a leading neurosurgeon. The first U.S. gastrectomy for peptic ulcer disease, was performed by Dr. A.A. Berg in 1922. The 1932 publication of Regional Ileitis, now known worldwide as Crohns disease, by Drs. Leon Ginzburg, Burrill Crohn and Gordon Oppenheimer. The institutions first kidney transplant, performed by Dr. Lewis Burrows in 1967. The first liver transplant in New York State was done here in 1988. The first minimally invasive repair of an abdominal aortic aneurysm in North America was performed by Dr. Michael L. Marin in 1992.
Dr. Arthur H. Aufses
Mount Sinai Department of Surgery
The Mount Sinai Hospital Second Location 1872

Dr. Arpad Gerster
It is part of our history to strive for greatness and lead the way for surgical
Dr. Howard Lilienthal
innovation. Many of the most important advances in surgery over the past 150 years originated within the halls of The Mount Sinai Hospital. - Arthur H. Aufses, Jr., M.D., former Chairman, Department of Surgery
Dr. Richard Lewisohn
Dr. Leon Ginzburg
Dr. Charles Elsberg
A. A. Berg
Clinical Operations
The Mount Sinai Department of Surgery is led by Michael L. Marin, M.D. one of the worlds leading vascular surgeons. He oversees nine clinical divisions: General Surgery, Colon and Rectal Surgery, Laparoscopic and Minimally Invasive Surgery, Organ Transplantation, Pediatric Surgery, Plastic and Reconstructive Surgery, Surgical Intensive Care, Surgical Oncology and Vascular Surgery. Over the past three years, surgical hospital discharges have increased by 14 percent; outpatient visit volume has grown by 43 percent; and our new Ambulatory Surgery Center has opened. The Faculty Practice Associates is located on the main campus between 98th and 101st street on Fifth Avenue. There are 132 faculty members in the Department of Surgery, located throughout Manhattan and Queens. Great pride is taken in caring for patients at our affiliate institutions as well. Our faculty, staff, residents and medical students provide surgical services at these important affiliates: Elmhurst Hospital in Queens, part of the New York City Health and Hospitals Corporation, Elmhurst, N.Y.; The Bronx Veterans Administration Hospital, also known as the James J. Peters VA Medical Center, Bronx, N.Y.; North General Hospital in Harlem, New York, N.Y.; Englewood Hospital, Englewood, N.J.; and Queens Hospital Center, part of the New York City Health and Hospitals Corporation, Jamaica, N.Y. Our third year residents also complete a life-changing rotation at the Juan Pablo Pia Hospital in San Cristobal, Dominican Republic, where they offer surgical care to this rural community.
Inside the walls of The Mount Sinai Medical Center, our surgeons build upon a legacy of those who have gone before, caring for the very sickest of patients, while developing new therapies and training tomorrows physicians to save and enhance lives.
Areas of Growth in the Mount Sinai Department of Surgery
*excludes Affiliate Faculty
WHATS NEW
Ambulatory Surgery Center The Department of Surgery at Mount Sinai is excited to announce the opening of the Medical Centers first dedicated outpatient operating suite. With two spacious operating rooms equipped with the latest technology and one convenient procedure room, the ambulatory surgery suite allows patients to undergo outpatient procedures in the confines of a safe and comfortable facility, just steps from their physicians offices. While our patients or family members wait they are able to enjoy a view of Central Park, as well as amenities such as satellite television, XM radio, computer to check email or browse the internet, and a courtesy phone for local calls. Procedures are performed by surgeons from Mount Sinais Faculty Practice Associates and anesthesia is provided by physicians from the Department of Anesthesiologys outpatient anesthesia group. In addition, the suite is staffed by its own dedicated team of highly-trained nurses and surgical technicians. As our patient base grows and outpatient surgeries increase our team is committed to excellence and providing an appropriate way to care for our community. The Department of Surgery takes pride in our premier team of surgeons, professional ability, state-of-the-art technology, and the highest quality of care. Department of Surgery Conference Center In the last year the Department of Surgery constructed a Conference Center. From large association or board meetings to more intimate gatherings, the room is perfect for all events. Our contemporary folding wall, one of just two in the country, gives us the option to divide the room in half so our space is always utilized efficiently. The centerpiece of the Conference Center is a state-of-the-art videoconferencing facility. With four large flat screen displays, and multiple remotely-controllable video cameras allowing full view of the podium speaker and audience; our conferencing system provides full 2-way communication between the Conference Center and remote locations, such as the operating rooms. Operating Room Storz System Our new OR Storz System offers surgeons seamless connectivity with surgical teams, regardless of their location. The system is connected to the Medical Center information infrastructure through a direct fiber optic link, extremely high-bandwidth communication, where data transfer can be achieved. It allows us to establish direct communication from our new Department of Surgery Conference room, to other local conference rooms or operating rooms at the Medical Center as well as with normally inaccessible conference locations throughout the world. Both the speaker and the audience are fully able to interact in real-time with the linked in conference center. By providing a valuable physician training and collaboration tool, the Storz system brings surgical mentoring to a new dimension. No matter what the purpose; we are empowered and capable of speaking with other medical universities and faculty anywhere.
HIPEC Treatment A new and advanced procedure called Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is being administered to patients here at Mount Sinai. The procedure is currently used in approximately 30 hospitals throughout the U.S. HIPEC is a procedure that combines surgery to remove tumors within the peritoneal (abdominal) cavity, with the administration of a solution containing chemotherapy. The solution is heated above body temperature and delivered directly into the cavity. Over approximately two hours, the solution is continuously circulated throughout the abdomen. Contrary to standard chemotherapy, by concentrating on only one part of the body, there is reduced toxicity to the rest of the system. This treatment is only used for carefully selected cancer patients with tumors limited to the peritoneal cavity. Mount Sinai Department of Surgery Melanoma Program Recently the Department of Surgery established the Mount Sinai Melanoma Program to provide the highest quality care to our patients with melanoma and related disorders. This includes access to a team of highly qualified health care professionals and state-of-the-art standard and experimental treatments. Mount Sinai has made a significant commitment to fighting these diseases emphasizing surgical, biologic and immunotherapy for the treatment of melanoma and other cancers.
Beating the Odds Prior to visiting Mount Sinai, Assya Baradov could not seem to find a hospital that she truly felt comfortable with or a program that really fit her needs. Assya told us, I really wanted someone that would treat me as a person not just a patient. She would not settle for less and finally found those attributes in our team here at Mount Sinai. Ms. Baradov, who at the time was 6-8 months post partum with her second child, came to us with an enlarging abdomen. Initially many believed she had ovarian cancer. Upon her arrival at Mount Sinai and under the care of Dr. Daniel Labow, Ms. Baradov was diagnosed with an advanced stage of gastric cancer; that in many cases would be seen as untreatable. Dr. Labow first performed surgery to remove all the visible tumors in the peritoneal cavity. A new and advanced procedure called Hyperthermic Intraperitoneal Chemotherapy (HIPEC) was then administered, followed by 8-9 months of normal chemotherapy treatment. HIPEC is a solution containing chemotherapy which is heated to a temperature 41 degrees greater than normal body temperature and delivered directly to the abdominal cavity, to kill any residual or hidden tumor cells. When asked about her experience at Mount Sinai, she said it was, Awesome. Im very, very happy with everyone. All the people are great - so caring and nice. As time moves forward and her surgery becomes something of the past, Assya mentioned that the care continues. I call sometimes and everyone is very responsive and friendly, she stated. They know me by my first name. Assya Baradov is now 18 months post diagnosis and is free of disease. She is very happy with Mount Sinai. I needed something innovative and customized to my needs and that is what I got. Other places didnt offer that.
Surgical Innovations
Minimally Invasive Surgical Innovations
Mount Sinai surgeons are world leaders in the research, development and the implementation of minimally invasive surgery. Minimally invasive treatments often improve clinical outcomes and result in less pain and a faster recovery than conventional surgical therapeutic procedures. Today, a majority of our general surgical procedures done at The Mount Sinai Hospital are performed using minimally invasive surgical techniques. Every division within the Department of Surgery focuses on minimally invasive approaches. Laparoscopic surgery generally uses fiber optic technology and special video cameras and instruments that are inserted in the body through tiny openings. These devices allow surgeons to see inside the body and perform remote operations while viewing the camera image on a video monitor. Although the exact techniques vary from specialty to specialty, there are many similar technologies. Colon and Rectal Surgery The majority of patients with Crohns disease who require surgery will have laparoscopic surgery to remove or repair a part of their intestine. Mount Sinai surgeons were the first in the world to routinely perform this procedure using minimally invasive techniques and now perform the majority of intestinal surgeries in this manner. Surgeons also routinely perform laparoscopic colectomy to remove parts of the colon containing cancerous tumors, as well as nearby lymph nodes. Mount Sinai surgeons participated in the national randomized trial of laparoscopic surgery for colon cancer, during which survival rates where found to be equal to those of traditional open surgery techniques. Organ Transplantation Mount Sinai surgeons performed the first laparoscopic donor nephrectomy in New York State in 1996. Using a tiny surgical telescope to see inside the patient, the surgeon removes the kidney through an incision located in a concealed place that is roughly three inches long. The procedure has a shorter recovery time than open surgery. Today, the majority of kidneys are harvested from living related donors using this minimally invasive technique. Vascular Surgery With nationally and internationally recognized leaders in the development of procedural techniques, Mount Sinai continues to perform extensive research in advancing the field of vascular surgery. Recent breakthroughs give patients several options for treating aneurysms in the aorta, optimizing care for patients. The development of new techniques to prevent stroke have been carried out here as well. Mount Sinai has built a reputation as a leader in treating these lifethreatening conditions with minimally invasive techniques. Mount Sinai surgeons were the first in the nation to perform minimally invasive endovascular aortic aneurysm repair in 1992. This procedure strengthens the aorta by relining the damaged part which excludes the weakened area from arterial pressure to prevent rupture. Mount Sinai surgeons have also participated in advancements with minimally invasive treatments of blocked arteries in the legs. Additionally, throughout the years, Mount Sinai vascular specialists have trained many practitioners in the U.S. to use these advanced surgical techniques. Pediatric Surgery The pediatric surgery team at Mount Sinai understands the stress parents experience when a child faces a surgical operation. To make these operations as comfortable for the child as possible, they are frequently performed using a minimally invasive approach. This technique is most often used for procedures affecting the chest and abdomen, including cholecystectomy, splenectomy, intestinal resection, fundoplication, and pull-through procedures. Minimally invasive approaches can be used for emergency procedures such as appendectomy, reduction of intussusception and even urgent surgery in newborns, such as pyloric stenosis. Congenital abnormalities of the lungs and abdominal organs can also frequently be approached with minimally invasive techniques. Bariatric Surgery Distinguished as an American Society for Metabolic and Bariatric Surgery (ASMBS) Center of Excellence, The Mount Sinai Program for Surgical Weight Loss has extensive experience performing the latest techniques in minimally invasive weight loss surgery. Mount Sinai surgeons were early developers of the minimally invasive treatment for obesity. This includes laparoscopic gastric bypass, now the most common weight loss operation in the U.S. Other procedures include laparoscopic adjustable gastric binding, sleeve gastrectomy and biliopancreatic diversion with duodenal switch (BPD-DS). These minimally invasive operations help people achieve a healthier weight with limited surgical procedures.
Invasive Surgical Innovations

The Mount Sinai Department of Surgery routinely implements groundbreaking surgical treatments. In many cases the Department first developed the new procedures that others seek to emulate. The variety of work extends from hernia repair to liver transplants. Hernia Repair Mount Sinais expertise in repairing hernias is well known throughout the region. More procedures of this type are done here than at any other medical institutions in New York City. Mount Sinai surgeons have had considerable success using complex new mesh prostheses for repair of hernias to help prevent recurrence and have particular expertise in treating paraesophageal, hiatal, inguinal, ventral and parastomal hernias. Restorative Proctocolectomy Much of our work in the treatment of patients with ulcerative colitis focuses not only on treating our patients but also improving our patients quality of life. Restorative Proctocolectomy (J-pouch surgery) avoids the need for intestinal stomas (ostomy bags) and preserves continence in patients who require the removal of the rectum. Since 1979, Mount Sinai surgeons have performed over 2,000 of these procedures, more than almost any other medical center in the world. Breast Reconstruction Immediate breast reconstruction at the time of mastectomy surgery is now available to most women undergoing treatment for breast cancer. This procedure includes the use of the patients own skin, muscle and vascular tissues transplanted from another region of the body to reconstruct and form the contours of a new breast and nipple. Having this procedure performed at the same time as a cancerous breast is removed greatly improves the quality of a breast cancer survivors life. Facial Reanimation Patients who have been severely disfigured or have lost the nerve function to important muscles of the face can achieve nerve stimulation and facial expression through facial reanimation surgery. This involves complex microsurgical nerve grafting therapies, which is one of our specialties. Mount Sinai receives patients from all over the world for this extraordinary procedure. Liver Transplant Mount Sinai was one of the leaders on the East Coast in the development and implementation of liver transplant surgery. Early work by the Mount Sinai liver transplant team resulted in the development of techniques to use portions of one liver for several donors, as well as expanding the capacity for the use of liver tissue from living related donors.
Hannahs Story Today Hannah Wolfson is a thriving little girl, full of energy and smiles, and growing well. But this was not the case when Hannah was born; a large cyst, discovered prenatally, was found to take up more than half of her abdomen. Hannahs parents were terrified. The Wolfsons were referred to pediatric surgeon, Dr. Peter Midulla, who recommended that a cyst this large be completely removed. Although it had not been done before on a baby this small, he felt that the surgery should be done laparoscopically in order to avoid a large painful incision and scar. According to Hannahs parents, Dr. Midulla was very patient with us. Anytime we called, he had the time to talk to us. In most circumstances, the procedure to remove a cyst is relatively routine. In this case however, the surgery posed a much higher degree of difficulty since Hannah was a newborn. Due to her small size Dr. Midulla recommended that the surgery be delayed a few months; he wanted to allow time for Hannah to grow which would make the laparoscopic approach easier. A short time later, Michelle Wolfson, Hannahs mother, called Dr. Midulla she was worried about her daughter and the continued growth of the cyst. To provide comfort for the family Dr. Midulla increased the monitoring with additional sonograms, so they could see that the cyst wasnt growing out of control as they waited to perform the surgery. The surgery was a huge success. The cyst was removed laparoscopically with only three tiny holes in the abdomen. The cyst turned out to be a large hepatic cyst, making this the first procedure of its kind ever done in an infant. Hannahs mother told us that, Dr. Midulla was amazing and the staff was fabulous. Everyone was so nice, which makes a difference when youre scared. As soon as the cyst was removed, Hannahs condition improved. She was more energetic, smiling constantly and started gaining weight. We have had the best possible outcome from the surgery that we could ask for. We are so grateful he was wonderful. We are thrilled with the way things turned out.
GLOBAL INITIATIVE
The Department of Surgery has established and continues to grow longstanding relationships with developing countries. Mount Sinai surgeons are proud to be working in affiliation with many different organizations throughout the globe.
Mount Sinai surgeons have a long history of participation in international health activities. This dates back to the post World War II period when Arthur J. Barsky, M.D., then Chief of Plastic Surgery, and his colleagues participated in the Hiroshima Maidens project which offered reconstructive plastic surgery procedures to Japanese women who were victims of the atomic bomb blast and had severe disfiguring injuries. During the Vietnam War, Dr. Barsky founded Childrens Medical Relief International (CMRI), an organization that built and staffed a childrens surgical hospital in Ho Chi Minh City (Saigon). Some 10,000 children had reconstructive plastic surgery at that hospital. Lester Silver, M.D., the present Chief of Plastic Surgery was the Chief of Professional Services at that hospital until the end of the war in 1975. Since that time, Dr. Silver and his colleagues in the Mount Sinai Medical Center Division of Plastic Surgery have been active in missions to provide surgical care in several countries in the Caribbean, Asia, South America, Africa and India. These missions provide operative services as well as training of host surgeons. In Peru, a team of surgeons from several academic institutions including Mount Sinai perform craniofacial reconstructive surgery (skull/midface/jaw) for children each year. This complex surgery is not available in many countries. The primary goal is to make a lasting difference in the lives of these children, and allow them to become productive members of their community. Beginning in 1993 the Indonesian Society of Critical Care Medicine and the Mount Sinai Division of Surgical Critical Care started a yearly symposium on Critical care Medicine and Shock. That meeting, eventually, evolved into the major Critical Care Symposium in Southeast Asia. Speakers are attracted from every continent and it is attended by up to 1,000 participants. In the spring of 2008, Dr. Silver and a team of Mount Sinai plastic surgeons: Dr. Richard Skolnik (Attending), Dr. C. Andrew Salzberg (Attending), and Dr. Hengli Lin (Plastic Surgery Resident) spent several weeks in Hue, Vietnam, at the invitation of the Trantien Foundation. The group performed surgery at the Hue Central Hospital as well as participating in a two day seminar devoted to updates in Plastic Surgery. Surgeons from throughout all regions of Vietnam were in attendance. This is planned as a long term project between the Trantien Foundation and the Mount Sinai Plastic Surgery Division. The Department of Surgery has also implemented a program in which the third year general surgery residents travel to the Dominican Republic and perform surgery for a four week period. The surgical resident rotation has been implemented at the Juan Pablo Pia Hospital located about an hour outside of the capital of Santo Domingo, to provide surgical care to a rural population. The hospital treats the people in the provinces of San Cristobal and Peravia.
10 Mount Sinai Department of Surgery
A Fathers Perspective Dylan Visioli is a delightful three-year-old boy who should not have had to worry about hospitals, tracheostomies or jaw surgery. Dylan was born in the summer of 2006 with a congenital anomaly of his lower jaw and airway, which had pronounced effects on his ability to speak and eat; tasks we take for granted. Dylans parents were scared and didnt know where to turn or whom to listen to for advice regarding the care of their child. Shortly after birth, Dylan required the placement of a tube into his windpipe to help him breathe. At one year of age he was seen by Dr. Michael A. Rothschild, the Chief of Pediatric Otolaryngology at Mount Sinais Kravis Childrens Hospital. Upon examination, he felt he might expedite the removal of the tracheostomy in Dylans airway by surgery on the lower jaw. He was then referred to Dr. Peter J. Taub, Co-Director of the Mount Sinai Cleft and Craniofacial program. Contrary to prior experience with physicians, Dylans father was pleased that both Drs. Rothschild and Taub were able to see the family right away. We got there early for an eleven oclock appointment with Dr. Rothschild, and shortly thereafter we had seen both him and Dr. Taub. Dr. Taub spent time with the family carefully explaining that Dylan could benefit from a technique known as distraction osteogenesis; a procedure that lengthens the lower jaw. With this surgery Dylans airway could be improved to the point where he would no longer require the tube at the base of his neck. While many of the other physicians the family had originally seen were indifferent, Dylans father explained that, Dr. Taub was very understanding and optimistic. He put our minds at ease and wasnt dismissive at all. Within 24 hours of the surgery, it was like nothing was done; and the surgery went incredibly smooth. I cant believe we waited so long. After only two weeks Dylan was eating without a problem and burbling happily. To the Visiolis surprise, When Dr. Taub was out of the country for a short time after the surgery he was in constant email contact and even called at one point. The family told us that they had an amazing experience at Mount Sinai. Everyone is great and efficient at what they do. Dylans father did mention however, The one regret we have is that we didnt contact Mount Sinai right away.
11
Research
Tomorrows cures start with todays research.
Mount Sinai is internationally known for its dedication to research. The Mount Sinai Medical Center is home to an extensive array of top-notch research centers and laboratories, where scientists and researchers work to translate the rapid advances in basic science into the innovative patient care for which our institution is known. Liver Cancer Program Mount Sinai is currently the leading clinical center in the U.S. treating patients with primary liver cancer, with over 400 new patients seen annually. The Mount Sinai Liver Cancer Surgery Program was formally initiated in 2005 by Myron E. Schwartz, M.D. and Sasan Roayaie, M.D., of the Department of Surgery and Josep M. Llovet, M.D., a hepatologist from Barcelona and one of the worlds leading authorities in clinical hepatocellular carcinoma (HCC) research. It was structured as a multidisciplinary group including hepatologists, surgeons, oncologists, pathologists, radiologists, personalized medicine and molecular biologists. The past few years have been marked by rapid progress that has placed Mount Sinai among the foremost centers worldwide in understanding the genomics (causative genes) of HCC. Mount Sinai has also been leading the international Panel of Experts in HCC by designing and leading clinical trials to find a cure. Vascular Surgery The Division of Vascular Surgery is performing many cutting edge therapies as part of ongoing clinical trials. These novel therapies are generally designed to decrease the invasiveness of a procedure, making them safer, less painful and requiring shorter hospital stays. Some of the studies underway include: carotid artery stenting to prevent stroke; endovascular grafting for the treatment of thoracic and abdominal aortic aneurysms to prevent rupture; stem cell therapy to increase circulation to the legs; and stents to increase blood flow and circulation to the pelvis and legs. Mount Sinai vascular surgeons have participated in more than 10 clinical trials for the development of endovascular stent graft devices and have invented significant technologies that have enabled the advancement of endovascular techniques. Crohns Disease and Ulcerative Colitis Mount Sinai continues to perform some of the countrys most complex procedures for Crohns disease and ulcerative colitis. Our surgeons have studied the use of minimally invasive techniques for these operations, including intestinal resections for Crohns and J-pouch surgery for ulcerative colitis. They are also involved in studies on duodenal Crohns, strictureplasty procedures for Crohns and identifying and treating cancers that occur in some patients with longstanding inflammatory bowel disease. Mount Sinai surgeons are currently collaborating with gastroenterology and pathology colleagues on a variety of surveillance studies, to help identify which of these patients are at particular risk of developing colorectal cancers. Mount Sinai Department of Surgery Melanoma Program The Department of Surgery is exploring translational research by integrating high quality clinical care with innovative advances in basic science. The Mount Sinai Department of Surgery Melanoma Program will emphasize translational research through bringing together expertise in surgical management, biological treatment and immunotherapy for patients with melanoma and other cancers. With such an outstanding reputation for patient care and research, alongside our commitment and hard work, Mount Sinai aims to become a world leader in translational research. The Melanoma Program will concentrate on developing new therapies for the treatment of melanoma, the most serious type of skin cancer. Currently, melanoma accounts for over 62,000 cases of skin cancer each year. With a combination of surgery and an innovative approach to diagnosis and treatment, we hope to bring cutting edge breakthroughs to our patients. The team also hopes to cultivate new therapeutic strategies using vaccines and the bodys own immune system to treat melanoma and other cancers.
I am especially looking forward to working closely with the highly-skilled
physicians and world-class scientists at Mount Sinai, to develop a translational research program that will bring the latest advances in the treatment of melanoma and other diseases to our patients. -Howard L. Kaufman, M.D.
Education & Residency

The Mount Sinai Hospital is one of the nations oldest and largest voluntary teaching hospitals. Today, the General Surgery Residency Program has 73 house officers and 132 faculty members who are dedicated to patient care, teaching and research. The Mount Sinai program emphasizes mentoring. This process lays the foundation for sound decision making and builds a strong support system. Our program is only as successful as our alumni. During the last five years, graduates have achieved a 100 percent first-pass rate on the American Board of Surgery board examinations. Surgical Residency and Fellowships Mount Sinai surgeons are committed to patient care and to training the next generation of surgeons. Residency programs are offered in General Surgery, Plastic and Reconstructive Surgery and Vascular Surgery. Fellowships are offered in Colon and Rectal Surgery, Critical Care Medicine, Laparoscopic Surgery, Surgical Oncology, and Transplantation. The Mount Sinai General Surgery Residency Program provides a solid foundation in general surgery, as well as clinical experiences in all surgical specialties. Particular emphasis is given to minimally invasive and endovascular techniques. Residents have published extensively in peer-reviewed journals and go on to fellowships and academic appointments at some of the nations most prestigious institutions. Graduates from Mount Sinai training programs have become leaders in virtually every surgical specialty. Surgical Education of Medical Students CT Scan Study The Medical Student Education Program is conducting a novel study using CT scans to image cadavers prior to anatomic dissection. This allows our students to study surgical diseases as they appear in a common CT scan and allows for direct comparison to the anatomy during traditional dissection teaching. Third Year Surgical Rotation in the Dominican Republic One of the most gratifying experiences for our third-year surgical residents is a rotation at the Juan Pablo Pia Hospital in San Cristobal, Dominican Republic. During the last academic year, five Mount Sinai residents did a rotation there. Armed with a background in the science and techniques of surgery, this future generation of surgeons learns the true art of practicing surgery, without the latest diagnostic equipment, surgical devices or anesthesia machines. During a six-week period, our residents learn about their ability to literally change lives. Surgical Simulation Center Surgical residents are offered the opportunity to spend extended periods of time in the Surgical Simulation Center, which promotes the acquisition of skills for the mastery of surgical techniques. The Center is equipped with state-of-the-art laparoscopic and endoscopic simulators, inanimate models and Web-based learning modules. Faculty members work with residents and students during scheduled training sessions to instruct on appropriate surgical techniques. In addition, junior and senior residents are intermingled in their assigned training sessions to simulate collaboration in performing various surgical procedures. Mount Sinai is on the leading edge of surgical simulation and our surgeons are working on several programs to enhance the future of this experience.
13
Colon & Rectal Surgery

Colon and Rectal Surgery Faculty
David Chessin, M.D. Stephen Gorfine, M.D. Adrian Greenstein, M.D. Michael T. Harris, M.D. Tomas Heimann, M.D. Amit Khanna, M.D. Sanghyun Alexander Kim, M.D. Alex Ky-Miyasaka, M.D.
Division of Colon and Rectal Surgery

The Mount Sinai Medical Center has a long history of performing colon and rectal surgeries. The Division of Colon and Rectal Surgery has a legacy of excellence and is a world leader in the treatment of gastrointestinal disorders. Our surgeons treat a wide range of diseases involving the colon and rectum, including inflammatory bowel disease (Crohns disease and ulcerative colitis), diverticulitis and colon and rectal cancers as well as other procedures not widely available. The surgical team is among the first and only in New York to perform transanal endoscopic microsurgery (TEM) and stapled transanal rectal resection (STARR). Mount Sinai surgeons apply minimally invasive techniques and a multidisciplinary approach to all aspects of colon and rectal surgery. This includes the laparoscopic resection of colon and rectal cancers. In addition to treating cancers, a partnership exists with the Department of Molecular and Cell Genetics in an effort to determine the genetic basis of colorectal cancers, as well as to develop novel screening techniques designed for early cancer detection.
Randolph Steinhagen, M.D.

Chief, Division of Colon and Rectal Surgery
14
General Surgery
General Surgery Faculty
Robert Aldoroty, M.D. Arthur H. Aufses, Jr., M.D. Mala Balakumar, M.D. Joel J. Bauer, M.D. Howard Beaton, M.D. Bernard Biviano, M.D. Norman Bloom, M.D. George Bock, M.D. Kerri Buch, N.P. Edward Chin, M.D. Sergei Dolgopolov, M.D. Michael Drew, M.D. Herschel Flax, M.D. Jeffrey Freed, M.D. Alisan Goldfarb, M.D. Stephen Goldstone, M.D. Marc Greenberg, M.D. Fredric Harris, M.D. Susan Kaiser, M.D. Un-Sup Kim, M.D James Lin, M.D. Chun Loh, M.D. Richard Lopchinsky, M.D. Panagiotis Manolas, M.D. Fred Moqtaderi, M.D. Naris Nilubol, M.D. Scott Q. Nguyen, M.D. Benjamin Pace, M.D. David Pertsemlidis, M.D. Demetrius Pertsemlidis, M.D. Jean Bernard Poulard, M.D. Vladimiro Rosenberg, M.D. Han-Yu Shen, M.D. Gary Slater, M.D. Moises Tenembaum, M.D. John Tomasula, M.D. George Tsioulias, M.D. Kaare Weber, M.D. Joel Zinberg, M.D.
Division of General Surgery

Since 1855, Mount Sinais general surgeons have played a key role in the hospitals growth and evolution. Today, the Division of General Surgery provides surgical treatment for a wide range of conditions, including the repair of abdominal wall hernias, removal of abdominal solid organs, excision of gastrointestinal tumors such as cancer of the colon and rectum, removal of the gallbladder, management of breast disease and surgical emergencies of the abdomen such as peritonitis, diverticulitis, appendicitis, and bowel perforation. The division also includes endocrine surgery to treat diseases and tumors of the thyroid and parathyroid glands, adrenal glands and pancreas. Working closely with the Department of Geriatrics, General Surgery has developed specialized expertise in Geri-Surgery or the management and surgical treatment of a wide spectrum of diseases in the elderly population. Extensive experience and a multidisciplinary approach have been critical to our superior outcomes. This has redefined the indications and removed the barriers for surgical intervention in this population. Surgical therapy is individualized to each patient and treatment options range from advanced laparoscopic procedures to lengthy and complex abdominal operations. Faculty members have specialized training within the broad spectrum of general surgery and have redefined the concept of the modern-day general surgeon. We continue to improve and refine our techniques in minimally invasive surgery to benefit our patients. The Division now offers single port surgery for gallbladder disease and laparoscopic retroperitoneal approach to adrenal surgery further reducing pain, recovery time and scars. For a wide range of specialties, including Urology, Gynecologic Surgery, Orthopedic and Cardiothoracic Surgery, the Division of General Surgery lends its expertise and assistance across the entire medical center.
Celia M. Divino, M.D.

Chief, Division of General Surgery
15
Laparoscopic & Minimally Invasive Surgery

Laparoscopic and Minimally Invasive Surgery Faculty
Michael Edye, M.D. Daniel Herron, M.D. Larry Gellman, M.D. Brian Jacob, M.D. L. Brian Katz, M.D. Subhash Kini, M.D. Mark Reiner, M.D. Rebecca Solomon, R.D. Anthony Vine, M.D. Sharon Zisman, M.D.
Division of Laparoscopic and Minimally Invasive Surgery

By combining advanced technology with patient care, minimally invasive surgeons are truly able to do more with less. Patients are experiencing less pain, shorter hospital stays and faster recovery times than was ever imaginable just 20 years ago. Mount Sinai surgeons include the worlds most respected and innovative surgeons who perform more laparoscopic procedures than at any other hospital in New York. Using minimally invasive surgical procedures, surgeons at Mount Sinai have successfully treated thousands of patients, trained hundreds of surgeons through fellowships, teach continuing medical education courses and engage in research contributing to the advancement of new surgical techniques and instruments. Mount Sinai surgeons have introduced many now-common laparoscopic procedures. Division Chief, Barry A. Salky, M.D. performed the first laparoscopic cholecystectomy in Barry A. Salky, M.D.
Chief, Division of Laparoscopic and Minimally Invasive Surgery
New York in 1990. Other procedures pioneered at Mount Sinai include laparoscopic pancreatic resection, laparoscopic donor nephrectomy, laparoscopic intestinal resection for Crohns disease, paraesophageal hiatal hernia repair and Heller myotomy for achalasia. Many of the minimally invasive surgical treatments for morbid obesity were developed here and have now become the standards of care around the world.
16
Organ Transplantation
Organ Transplantion Faculty
Scott Ames, M.D. Juan del Rio Martin, M.D. Kishore Iyer, M.D. Susan Lerner, M.D. Gonzalo Rodriguez-Laiz, M.D. Hiroshi Sogawa, M.D. Mark Sturdevant, M.D.
Division of Organ Transplantation

The Division of Organ Transplantation includes a robust group focused on the transplantation of the liver, kidney, pancreas and small intestine. Mount Sinai was one of the leaders on the East Coast in the development and implementation of liver transplant surgery. Early work by the Mount Sinai liver transplant team resulted in techniques for combining living donor liver and kidney transplants, as well as domino split liver transplants in which multiple patients receive parts from one donor liver. New Yorks first liver transplant was performed at Mount Sinai in 1988. Since then, more than 3,000 patients have received new livers at Mount Sinai, making the program the third largest program in the world. Over the past few years, Mount Sinai has also become one of the largest renal transplant centers in the New York metropolitan area and was one of first programs in the country to perform laparoscopic nephrectomies on living kidney donors, a procedure which dramatically reduces recovery time for individuals who donate a kidney to a loved one. The Divisions clinical work dovetails with a robust basic science laboratory program in organ transplantation, led by Jonathan S. Bromberg, M.D., Ph.D. Dr. Brombergs laboratory studies a number of areas associated with the control of the immune system following transplantation. Intensely committed to clinical and basic science research, members of the Transplantation Institute are presently investigating ways to improve organ preservation, reduce posttransplant complications and the side effects of immunosuppression, prevent or delay recurrence of disease after transplant and improve transplant organ and patient survival and quality of life.
Johnathan S. Bromberg, M.D.

Chief, Division of Organ Transplantation
17
Pediatric Surgery
Pediatric Surgery Faculty
Nanita Lim-Sulit, N.P. Edward Shlasko, M.D. Francisca Velcek, M.D.
Division of Pediatric Surgery

Surgeries involving children can be met with even more apprehension than those for adults. Fortunately, The Mount Sinai Division of Pediatric Surgery offers a full range of pediatric surgical procedures in a family-focused, childsensitive environment. From initial orientation through discharge, the team caters to the needs of this very special population. Mount Sinai is a referral center for complex, pediatric surgical problems referred from other regional hospitals. Our surgeons work closely with pediatric specialists throughout the institution to provide superior care. One example, within the Pediatric Surgery division is a partnership with the pediatric gastroenterology group to manage children with inflammatory bowel disease (IBD). Mount Sinais long history of successfully treating IBD in young patients builds on the institutions pioneering work in managing colon and rectal diseases. Whenever possible, our surgeons recommend minimally invasive techniques for pediatric Peter S. Midulla, M.D. patients. This means more than simply using Chief, Division of Pediatric Surgery the latest technology to perform advanced surgical procedures, it is also a philosophical approach to minimize trauma and discomfort for infants and children. The result is fewer complications and shorter hospital stays, ultimately resulting in less pain and anxiety. Since children typically heal more quickly than adults, theyre able to return to normal activities sooner.
Plastic & Reconstructive Surgery

Plastic and Reconstructive Surgery Faculty
Hiyad Al-Husaini, M.D. Jay Birnbaum, M.D. Stafford Broumand, M.D. Jin Chun, M.D. Michelle Copeland, M.D. Jeffrey Fischman, M.D. Barry Goldenberg, M.D. Marco Harmaty, M.D. Harvey Himel, M.D. Leo Keegan, M.D. Ernest Kirchman, M.D. John Ko, M.D. Adam Kolker, M.D. Aron Kressel, M.D. Malik Kutty, M.D. Elie Levine, M.D. Jay Meisner, M.D. Douglas Monasebian, M.D. Rosa Razaboni, M.D. Elliott Rose, M.D. Victor Rosenberg, M.D. Matthew Schulman, M.D. Richard Skolnik, M.D. Thomas Sterry, M.D. Peter Taub, M.D. Jess Ting, M.D. Michele Verga, M.D. Carlin Vickery, M.D. Hubert Weinberg, M.D.
Division of Plastic and Reconstructive Surgery

The Division of Plastic and Reconstructive surgery treats a wide range of patients in all age groups, with problems ranging from aesthetic to complex reconstructions. These conditions include both benign and malignant disease, as well as deformities that are either congenital or acquired, in varying anatomic locations. The aim of these procedures is to restore function as well as correct deformities seen at birth or due to aging, accident, or illness. Specific areas of expertise include general reconstruction, craniofacial surgery, microsurgery, hand surgery, and aesthetic surgery. The aesthetic surgery program at Mount Sinai makes use of the latest procedures and techniques to restore a persons natural, youthful appearance. Invasive and noninvasive techniques are stressed to minimize patient downtime and discomfort. The Mount Sinai Cleft and Craniofacial Program is the oldest multidisciplinary team in the metropolitan area. Throughout its history it has managed hundreds of children and adults with complex congenital anomalies of the head and neck. Similarly, the Mount Sinai Vascular Anomalies Program treats patients in a multidisciplinary setting with various congenital and acquired vascular lesions, including hemangiomas and vascular malformations. Microsurgical care involves the transfer of tissue from one area of the body to another to repair complex defects following trauma or surgery. Most notably, our breast reconstruction program utilizes the latest soft tissue flaps (TRAM, DIEP, SGAP flaps) to restore our patients natural form and beauty. Our hand surgeons focus on reconstruction of the hand and upper extremity to restore function and return patients to their occupation and avocations. Finally, the Division has a complex wound care program that sees both inpatients and office-based patients for wounds that wont heal with standard treatment measures. Many of the procedures can be performed on an ambulatory basis, while others require limited hospital admission. Our team takes immense pride in the quality of care we deliver to our patients and look forward to the coming year to tackle new challenges and improve the lives of our patients.
Lester Silver, M.D.

Chief, Division of Plastic and Reconstructive Surgery
2008-2009 Annual Report 19
Surgical Intensive Care

Surgical Intensive Care Faculty
Adel Bassily-Marcus, M.D. Neil Halpern, M.D. Roopa Kohli-Seth, M.D. Anthony Manasia, M.D. John Oropello, M.D.
Division of Surgical Intensive Care

Excellence and innovation are hallmarks of The Mount Sinai Surgical Intensive Care Unit (SICU). Since 1970, the Division has trained more than 170 critical care specialists, called intensivists. The SICU is an intensivistled multidisciplinary model of care aimed at improving patient outcomes, by providing state-of-the-art care to critically ill surgical patients who suffer from a wide range of lifethreatening conditions. The Division has pioneered the use of several leading-edge technologies to meet its patients special needs. These innovations include goal directed echocardiography, lung ultrasound and other non-invasive monitoring methods. Using these and other intensive care techniques and equipment, patients with the most complex forms of surgical issues are cared for through the most critical portions of their post-operative period before being stabilized and transferred to the conventional hospital floors. The Central Venous Access Service places over 1,500 central venous catheters annually Chief, Division of Surgical Intensive in non-ICU patients, 25% of which are Care Peripherally Inserted Central (PIC) catheters. This service operates out of a dedicated procedure room physically located within the confines of the SICU, and is equipped with its own fluoroscopy unit and Ernest Benjamin, M.D. ultrasound vessel finder probes. The Surgical Nutritional Support Service consists of physicians and nutritionists who manage the nutritional needs of both acutely ill and other patients, throughout the hospital. The team monitors their condition daily, providing parenteral nutrition and specialized enteral support. Mount Sinais rapid response team brings critical care expertise to the patients bedside wherever needed. This ICU without walls concept has been shown to improve health outcomes. Intensivists here also have broad expertise in blood purification for the critically ill. Patients with declining or failing kidney function receive gentle, continuous blood cleansing around the clock, a technique that the Division has perfected over the last 15 years. The Division is also involved in a number of clinical trials looking at both pharmaceutical and therapeutic techniques to enhance outcomes following intensive care unit management.
20
Surgical Oncology
Surgical Oncology Faculty
Cynara Coomer, M.D. Spiros Hiotis, M.D. Mary Margaret Kemeny, M.D. Howard L. Kaufman, M.D. Daniel Labow, M.D. Sasan Roayaie, M.D. Michail Shafir, M.D. Marshall Weiss, M.D. Christina Weltz, M.D.
Division of Surgical Oncology

Patients who have been diagnosed with cancer need an integrated team consulting on the unique aspects of their care. All cases at Mount Sinai are discussed by a team of medical and surgical experts, enabling patients to benefit from the opinions of dozens of nationally renowned doctors. The surgical team understands the emotional needs of cancer patients and knows that time matters. Patients are seen within 48 to 72 hours and when necessary, scans are reviewed the same day. With on-site experts to expedite evaluation, creating a customized treatment plan has become second nature. While surgery might be part of that plan, this needs to be properly timed and sequenced with other treatments such as chemotherapy and radiation. Ongoing clinical trials are being run on a regular basis to provide cutting-edge surgical therapy for patients with other advanced cancers. For instance, a new and advanced procedure called Hyperthermic Intraperitoneal Chemotherapy (HIPEC) has been administered here at Mount Sinai to carefully selected patients with tumors of the peritoneal cavity. Mount Sinai is currently the leading referral center in the U.S. for primary liver cancer. The surgical oncology team is involved with complex procedures that involve removing half or even more of the liver. This may mean full remission and/or cure for many patients whose cancers originated in the liver or elsewhere in the body, but which have metastasized to the liver. Pancreatic cancer has also become a major focus of the team. With over 100 resections in the last year, the Division is rapidly expanding this surgical specialty. Additionally, in partnership with the Department of Medicine, Mount Sinai is leading a program focused on treating neuroendocrine tumors. The relatively rare condition is unique in its need for interdisciplinary care of which we currently have the largest program on the East Coast.
Myron E. Schwartz, M.D.

Chief, Division of Surgical Oncology
21
Vascular Surgery
Vascular Surgery Faculty
Danielle Bajakian, M.D. Steven Elias, M.D. Sharif Ellozy, M.D. David Gitlitz, M.D. Moshe Haimov, M.D. Elizabeth Harrington, M.D. Martin Harrington, M.D. Tikva Jacobs, M.D. Julius H. Jacobson, II, M.D. Michael L. Marin, M.D. Harry Schanzer, M.D. Jeffrey Stein, M.D. Pinkus Szuchmacher, M.D. Victoria Teodorescu, M.D. Windsor Ting, M.D. Ageliki G. Vouyouka, M.D.
Division of Vascular Surgery

Over the past decade there have been dramatic advances in the treatment of patients with vascular disease. In the Division of Vascular Surgery our ongoing commitment to improving patient care has resulted in the development of new techniques to minimize discomfort and improve the outcome of treatment. Our emphasis on caring for the patient as a whole has resulted in more effective and comprehensive therapy. The wide array of patient services available within our vascular division ensures that nearly every condition can be managed successfully. The Vascular Surgery service at Mount Sinai has been responsible for many advances in vascular surgery. These include minimally invasive treatments for the prevention of stroke and for the repair of abdominal aortic aneurysms. Dr. Peter L. Faries, Chief of the Division of Vascular Surgery and Dr. Michael L. Marin, Chairman of the Department of Surgery, have assembled a team of world renowned surgeons.
Peter L. Faries, M.D Chief, Division of Vascular Surgery
Our vascular surgeons, together with outstanding physician care extenders and ancillary staff, are dedicated to achieving unsurpassed quality in patient care. Our team prides itself on providing the highest level of compassion and communication with our patients and families, serving as a model for medical centers worldwide.
22
Administrative Governance
David Kaplan
Cindy Nieves
Magali Torres
Cornelia Koehlen
Lois Shanahan
Randy Wellner
Alice Kwan
Saleha Ahmed
Shane Johnson
Caeli Sullivan
Moses Lopez
Fonda Sloan
Emily Westheimer
Elizabeth Eldridge
Derrick Taylor
Anne Hogan
23
Philanthropy
The Mount Sinai Medical Center is one of the top-ranked clinical and medical research institutions in the country; with more than 150 years of history of medical breakthroughs and ground-breaking achievements. This has only been possible because of the support of our friends and alumni. Our nationally and internationally recognized excellence in surgical education, research and patient care relies on philanthropy at all levels, to maintain its outstanding quality. Donors make a tremendous impact on our ability to continue our life-saving work. Your support will extend more than 150 years of preeminent excellence in the years to come.
Endowed Professorships
An opportunity for permanent legacy is through an Endowed Professorship. These Endowed Chair positions facilitate the recruitment and retention of our most prestigious surgical faculty. This gives donors an opportunity to direct their philanthropic efforts toward scientific achievement in perpetuity.
Existing Endowed Chairs

The Julius H. Jacobson II, M.D., Professor of Vascular Surgery Michael L. Marin, M.D., F.A.C.S. Chairman, Department of Surgery Eugene W. Friedman, M.D., Professor of Surgical Oncology Vacant. Alfred and Florence Gross, Professor of Surgery Jonathan S. Bromberg, M.D., Ph.D. Professor of Surgery, Immunology and Gene & Cell Medicine Chief, Division of Organ Transplantation Franz W. Sichel, Professor of Surgery Barry A. Salky, M.D., F.A.C.S. Chief, Division of Laparoscopic and Minimally Invasive Surgery Henry Kaufmann, Professor of Surgery Myron E. Schwartz, M.D., F.A.C.S. Chief, Division of Surgical Oncology Stanley Edelman, M.D., Professor of Surgery Celia M. Divino, M.D., F.A.C.S. Vice Chair, Education & Quality Chief, Division of General Surgery Program Director, General Surgery Residency
Fellowships
Named fellowships present an opportunity to support post-graduate training of residents, promote educational initiatives and stimulate research endeavors. This support is essential to the recruitment of our top-notch house officers.
Existing Named Fellowships

Dr. Ralph Colp Surgical Fellowship Fund Ruth J. and Maxwell Hauser Fellowship Fund, Department of Surgery Percy Klingenstein, M.D. Surgical Fellowship for Clinical Research in Surgery Gindel Residency Fund The Lotte and Randolph J. Sunshine Fellowship Fund
The Friends of The Mount Sinai Department of Surgery

The Department invites interested individuals to join The Friends of The Mount Sinai Department of Surgery. This community of dedicated supporters of our Department will be invited to participate in regular gatherings and departmental functions.
For further information about philanthropic opportunities, please contact: Randy Wellner Director of Development, Department of Surgery The Mount Sinai Medical Center 212-659-1592 randy.wellner@mountsinai.org
24
2008 Publications
COLON AND RECTAL SURGERY RANDOLPH STEINHAGEN, M.D., CHIEF Zhang LP, Steinhagen RM. Treating Crohns disease with hematopoietic stem cell transplantation. Surg Rounds 2008; 31:119-122. Ky AJ, Sylla P, Steinhagen RM, Steinhagen E, Khaitov S, Ly E,. Collagen fistula plug for the treatment of anal fistulas. Dis Colon Rectum, 2008; 51:838-843. Sylla P, Deutsch G, Luo J, Recavarren C, Kim S, Heimann TM, Steinhagen RM. Cavernous, arteriovenous, and mixed hemangioma-lymphangioma of the rectosigmoid: rare causes of rectal bleeding - case series and review of the literature. Int J Colorectal Dis. 2008; 23:653-658. Maun D, Silverberg D, Steinhagen RM. The authors reply. Dis Colon Rectum, 2008; 51:986. DAVID CHESSIN, M.D. Septic complications after restorative proctocolectomy do not impair functional outcome: long-term follow-up from a specialty center. Chessin DB, Gorfine SR, Bub DS, Royston A, Wong D, Bauer JJ. Dis Colon Rectum. 2008 Sep;51(9):1312-7. STEPHEN GORFINE, M.D. Stern D, Maun, D, Gorfine, SR, Bauer JJ. Pelvic Cancer Ten Years after Restorative Proctocolectomy in Indeterminate Colitis: Report of a Case. Dis Colon Rectum 2008;51:610-4, 2008 Jan 26. Edden Y, Ciardullo J, Sherafgan K, Harris MT, Bub DS, Gorfine SR, Bauer JJ. Laparoscopic-assisted ileocolic resection for Crohn's disease. JSLS 2008;12:139-42. Denoya PI, Schulander SJ, Bub DS, Gorfine SR, Bauer JJ. Delayed Kock pouch nipple valve failure: Is revision indicated? Dis Colon Rectum 2008;511312-7. Chessin DB, Gorfine SR, Bub DS, Royston A, Wong D, Bauer JJ. Septic Complications after Restorative Proctocolectomy do not Impair Functional Outcome: LongTerm Follow-Up from a Specialty Center. Dis Colon Rectum. 2008;51:1312-7. ADRIAN GREENSTEIN, M.D. MICHAEL T. HARRIS, M.D. Greenstein AJ, Litle VR, Swanson SJ, Divino CM, Packer S, McGinn TG, Wisnivesky JP. The Prognostic Significance of the Number of Lymph Node Metastases in Esophageal Cancer. Journal of the American College of Surgeons. 2008 Feb; 206(2):239-46. JACS CME-1 Featured Article. J Am Coll Surg. 2008 Feb;206(2): 401-403. Greenstein AJ, Litle VR, Swanson SJ, Divino CM, Packer S, McGinn TG, Wisnivesky JP. Racial Disparities in Esophageal Cancer Treatment and Outcomes. Annals of Surgical Oncology, 2008 Mar; 15(3):881-8. Greenstein AJ, Litle VR, Swanson SJ, Divino CM, Packer S, McGinn TG, Wisnivesky JP. Effect of the Number of Lymph Nodes Sampled on Postoperative Survival of Node-Negative Esophageal Cancer. Cancer. 2008 Mar 15; 112(6):1239-46. Greenstein AJ, Nguyen SQ, Buch KE, Chin EH, Weber KJ, Divino CM. Recurrence after Laparoscopic Ventral Hernia Repair: A Prospective Pilot Study of Sutures versus Tack Fixation. The American Surgeon. 2008 Mar; 74(3):227-31. Edden Y., Ciardulla J., Sherafgan K., Harris MT., Bud D., Gorfine S., Bauer J. Laparoscopic Assisted Ileocolic Resection for Crohns Disease. Journal of the Society of Laparoendoscopic Surgeons, 2008 April-June;139-142. Bauer JJ., Harris MT., Grumbach NM., Gorfine SR. Laparoscopic-assisted intestinal resection for Crohn's disease. Journal of the Society of Laparoendoscopic Surgeons 2008;12:139-142. Divino M, Divino., Shapiro, Mark., Greenstein J, Alexander., Byrn, John., Corona, Jacqueline., Greenstein J, Adrian., Salky, Barry., Harris MT., Surgical Management and Outcome of Patients with Duodenal Crohns Disease. Journal of The American College of Surgeons. 2008, 207(1): 36-42. TOMAS HEIMANN, M.D. Schnur,J, Nguyen, S, Divino, C, Heimann, TM. Coexisting Rectal and Urachal Carcinoma: A Case Report. American J Clin Oncol. 2008. Greenstein AJ, Litle VR, Swanson SJ, Divino CM, Packer S, McGinn TG, Wisnivesky JP. Effect of the Number of Lymph Nodes Sampled on Postoperative Survival of Node-Negative Esophageal Cancer. Cancer. 2008 Mar 15; 112(6):1239-46. Greenstein AJ, Nguyen SQ, Buch KE, Chin EH, Weber KJ, Divino CM. Recurrence after Laparoscopic Ventral Hernia Repair: A Prospective Pilot Study of Sutures versus Tack Fixation. The American Surgeon. 2008 Mar; 74(3):227-31. Chin EH, Baril DT, Weber KJ, Divino CM. Laparoscopic Cortical-Sparing Adrenalectomy for Bilateral Pheochromocytoma. Surg Endosc. 2008 Sep; 22 (9):2075. Greenstein AJ, Byrn JB, Zhang L, Swedish K, Jahn AE, Divino CM. Risk Factors for the Development of Fulminant Clostridium Difficile Colitis. Surgery. 2008 May;143(5):623-9. Sarpel U, Vladeck BC, Divino CM, Klotman PE. Fact and Fiction: Debunking Myths in the US Healthcare System. Ann Surg 2008 Apr;247(4):563-569. Shapiro M, Greenstein AJ, Byrn JC, Corona J, Salky B, Harris MT, Divino CM. Surgical Management and Outcomes of Patients with Duodenal Crohns Disease. Journal of the American College of Surgeons 2008 Jul; 207(1):36-42, *JACS CME-1 Featured Article. Branco BC, Sachar DB, Heimann T, Sarpel U, Harpaz N, Greestein AJ. Adenocarcinoma Complicating Restorative Proctocolectomy for ulcerative colitis with mucosectomy performed by Cavitron Ultrasonic Surgical Aspirator Colorectal Disease. Accepted for publication for December 2008. Branco, BC, Sachar DB, Heimann T, Sarpel U, Harpaz N, Greenstein AJ. Adenocarcinoma following ileal pouch-anal anastomosis for ulcerative colitis: review of 26 cases. Inflammatroy Bowel Disease Journal. Accepted for publication June 2008. Branco BC, Harpaz N, Sachar DB, Greenstein A, Tabrizian P, Bauer JJ, Greenstein A. Colorectal Carcinoma in Indeterminate colitis. Inflammatory Bowel Disease Journal. Accepted for publication December 2008. Sachar DB, Bauer J, Ullman T, Greenstein AJ. Recurrence patterns after first resection for Stricturing or Penetrating Crohns Disease. Inflammatory Bowel Disease Journal. Accepted for publication December 2008. Greenstein AJ, Byrn JB, Zhang L, Swedish K, Jahn AE, Divino CM. Risk Factors for the Development of Fulminant Clostridium Difficile Colitis. Surgery. 2008 May;143(5):623-9. Miller AT, Saadai P, Greenstein AJ, Divino CM. Post-Procedural Necrotizing Fasciitis: a 10 Year Retrospective Review. The American Surgeon. May 2008, Vol 74 (5):405-9. Greenstein AJ, Watson J, Divino CM; Pneumoperitoneum and Pneumatosis A Clinical Conundrum. International Journal of Surgery, 2008 Dec;6(6):e40-1. Eisenstein S, Greenstein AJ, Kim U, Divino CM. Cystic Duct Stump Leak: After the Learning Curve. Archives of Surgery. 2008 Dec;143(12):1178-83. Mazeh H, Greenstein AJ, Swedish K, Nguyen SQ, Lipskar A, Weber KJ, Chin EH, Divino CM. Laparoscopic and Open Reversal of Hartmanns Procedure A Comparative Retrospective Analysis. Surgical Endoscopy 2008 July 17. SANGHYUN ALEXANDER KIM, M.D. Sylla P, Deutsch G, Luo J, Recavarren C, Kim S, Heimann TM, Steinhagen RM. Cavernous, arteriovenous, and mixed hemangioma-lymphangioma of the rectosigmoid: rare causes of rectal bleeding - case series and review of the literature. Int J Colorectal Dis. 2008; 23:653-658. ALEX KY, M.D. Ky AJ, Sylla, P, Steinhagen E, Steinhagen R, Khaitov, Ly E Collagen Fistula Plug for the Treatment of Anal Fistulas. Dis Colon Rectum 2008. Ky AJ. The Surgisis AFP Anal Fistula Plug: Report of a Consensus Conference. Colorectal Dis 2008;10(1):17. GENERAL SURGERY CELIA M. DIVINO, M.D., CHIEF Pan PY, Wang GX, Yin B, Ozao J, Ku T, Divino CM, Chen SH. Reversion of immune tolerance in advanced malignancy: modulation of myeloid derived suppressor cell development by blockade of SCF function. Blood. 2008 Jan 1;111(1):219-28. Buch KE, Genovese MY, Conigliaro JL, Nguyen SQ, Byrn JC, Novembre CL, Divino CM. Non-physician practitioners overall enhancement to a surgical residents experience. Journal of Surgical Education 2008 Jan-Feb; 65(1):50-3. Byrn JC, Maun D, Ozao J, Gingold D, Divino CM; Predictors of Mortality after Colectomy for Fulminant Clostridium Difficile Colitis; Archives of Surgery, 2008 Feb;143(2):150-4. Greenstein AJ, Litle VR, Swanson SJ, Divino CM, Packer S, McGinn TG, Wisnivesky JP. The Prognostic Significance of the Number of Lymph Node Metastases in Esophageal Cancer. Journal of the American College of Surgeons. 2008 Feb; 206(2):239-46. JACS CME-1 Featured Article. J Am Coll Surg. 2008 Feb;206(2): 401-403. Greenstein AJ, Litle VR, Swanson SJ, Divino CM, Packer S, McGinn TG, Wisnivesky JP. Racial Disparities in Esophageal Cancer Treatment and Outcomes. Annals of Surgical Oncology, 2008 Mar; 15(3):881-8.
25
2008 Publications
Miller AT, Saadai P, Greenstein AJ, Divino CM. PostProcedural Necrotizing Fasciitis: a 10 Year Retrospective Review. The American Surgeon. May 2008, Vol 74 (5):405-9. Nguyen SQ, Divino CM, Buch KE, Schnur J, Webber KJ, Katz LB, Reiner MA, Aldoroty A, Herron DM. Postoperative Pain after Laparoscopic Ventral Hernia Repair: A Prospective Comparison of Sutures versus Tacks. Journal of the Society of Laparoendoscopic Surgeons (JSLS) 2008 Apr-Jun;12:113-116. Mazeh H, Epelboym I, Reinherz J, Greenstein AJ, Divino CM. Tip Appendicitis: Clinical implications and management. American Journal of Surgery. 2008 Sep 11. Buch KE, Tabrizian P, Divino CM. Management of Hernias in Pregnancy. Journal of the American College of Surgeons, 2008 Oct;207(4):539-42. Ozao-Choy J, Tammaro Y, Fradis M, Weber K, Divino CM. Clopidogrel and bleeding after general surgery procedures. The American Surgeon. 2008 Aug;74(8):721-5. Greenstein AJ, Watson J, Divino CM; Pneumoperitoneum and Pneumatosis A Clinical Conundrum. International Journal of Surgery, 2008 Dec;6(6):e40-1. Eisenstein S, Greenstein AJ, Kim U, Divino CM. Cystic Duct Stump Leak: After the Learning Curve. Archives of Surgery. 2008 Dec;143(12):1178-83. Mazeh H, Greenstein AJ, Swedish K, Nguyen SQ, Lipskar A, Weber KJ, Chin EH, Divino CM. Laparoscopic and Open Reversal of Hartmanns Procedure A Comparative Retrospective Analysis. Surgical Endoscopy 2008 July 17. Shapiro M, Greenstein AJ, Byrn JC, Corona J, Salky B, Harris MT, Divino CM. Surgical Management and Outcomes of Patients with Duodenal Crohns Disease. Journal of the American College of Surgeons 2008 Jul; 207(1):36-42. *JACS CME-1 Featured Article. Telem D, Chin EH, Colon M, Nguyen SQ, Divino CM. Minimally Invasive Surgery for Splenic Malignancies. Minerva Chi. 2008 Dec;63(6):529-40. ROBERT ALDROTY, M.D. Parastomal hernia repair using cross-linked porcine dermis: Report of a case. Greenstein AJ, Aldoroty RA. Surg Today. 2008;38(11):1048-51. Postoperative pain after laparoscopic ventral hernia repair: a prospective comparison of sutures versus tacks. Nguyen SQ, Divino CM, Buch KE, Schnur J, Weber KJ, Katz LB, Reiner MA, Aldoroty RA, Herron DM. JSLS. 2008 AprJun;12(2):113-6. JOEL J. BAUER, M.D. Stern D., Maun D., Gorfine s., Bauer JJ., Pelvic Cancer Ten Years after Restorative Proctocolectomy in Indeterminate Colitis: Report of a Case. Diseases of the Colon & Rectum. January 2008. Edden Y., Ciardullo J., Sherafgan W., Harris MT., Bub DS., Gorfine SR., Bauer JJ. Laparoscopic-Assisted Ileocolic Resection for Crohns Disease: Experience with 158 Patients. Journal of the Society of Laparoendoscopic Surgeons / Society of Laparoendoscopic Surgeons. 2008 Apr-Jun;12(2):139-42. Denoya P., Schluender S., Bub d., Gorfine S., Bauer JJ.,: Delayed Kock Pouch Nipple Valve Failure: Is Revision Indicated? Diseases of the Colon and Rectum. 2008 Oct;51(10):1544-7. David B. Chessin, M.D., Stephen R. Gorfine, M.D., David S. Bub, M.D., Aaron Royston, B.A., Deborah Wong, M.D.,and Joel J. Bauer, M.D. Septic Complications After Restorative Proctocolectomy Do Not Impair Functional Outcome: Long Term Follow-Up from a Specialty Center. Diseases of the Colon and Rectum. Volume 51, Number 9. 2008 June, 27. EDWARD CHIN, M.D. Chin EH, Baril DT, Weber KJ, Divino CM. Laparoscopic Cortical Sparing Adrenalectomy for Bilateral Pheochromocytoma (2008). Surg Endosc 22(9): 2075. Greenstein AJ, Nguyen SQ, Buch KE, Chin EH, Weber KJ, Divino CM. Recurrence after Laparoscopic Ventral Hernia Repair: a Prospective Pilot Study of Suture versus Tack Fixation (2008). Am Surgeon 74(3): 227-31. Mazeh H, Greenstein AJ, Swedish K, Nguyen SQ, Lipskar A, Weber KJ, Chin EH, Divino CM. Laparoscopic and open reversal of Hartmann's procedure-a comparative retrospective analysis. Surg Endosc. 2008 Jul 17. Telem D, Chin EH, Colon M, Nguyen SQ, Weber K, Divino CM. Minimally Invasive Surgery for Malignancies Involving the Spleen (2008). Minerva Chir 63(6): 529-40. Hazzan D, Chin EH, Salky BA (2008). Laparoscopic Nissen Fundoplication. In: John L. Cameron, ed. Current Surgical Therapy, 9th ed (1312-1316). Philadelphia, PA: Mosby, Inc. JEFFREY FREED, M.D. Relevant recertification-a problem for specialty boards. Freed JS. Am J Surg. 2008 Aug 21. Clinical effect of nemifitide, a novel pentapeptide antidepressant, in the treatment of severely depressed refractory patients. Feighner JP, Sverdlov L, Hlavka J, Nicolau G, Cartwright K, Freed JS. Int Clin Psychopharmacol. 2008 Jan;23(1):29-35. ALISAN GOLDFARB, M.D. Disrupted Sleep the Night Before Breast Surgery is Associated with Increased Postoperative Pain. Wright CE, Bovbjerg DH, Montgomery GH, Weltz C, Goldfarb A, Pace B, Silverstein JH. J Pain Symptom Manage. 2008 Aug 22. Anticipatory psychological distress in women scheduled for diagnostic and curative breast cancer surgery. Schnur JB, Montgomery GH, Hallquist MN, Goldfarb AB, Silverstein JH, Weltz CR, Kowalski AV, Bovbjerg DH. Int J Behav Med. 2008 Jan-Mar;15(1):21-8. Hypnosis decreases presurgical distress in excisional breast biopsy patients. Schnur JB, Bovbjerg DH, David D, Tatrow K, Goldfarb AB, Silverstein JH, Weltz CR, Montgomery GH. Anesth Analg. 2008 Feb;106(2):440-4, table of contents. STEPHEN GOLDSTONE, M.D. Stier E, Goldstone SE, Berry JM, Panther LA, Jay N, Krown SE, Lee J, Palefsky JM. Infrared coagulator treatment of high-grade anal dysplasia in HIV-infected individuals: An AIDS Malignancy Consortium pilot study. JAIDS, 47: 56-61, Jan 2008. Wexler A, Berson AM, Goldstone SE, Waltzman R, Penzer J, Maisonet O G, Mc Dermott B, Rescigno J. Invasive anal squamous cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy. DCR, 51: 73-81, Jan 2008. Goldstone SE. Invited Commentary on: High-Resolution anoscopy targeted surgical destruction of anal high-grade squamous intraepithelial lesions: a ten-year experience, Pineda CE, Berry JM, Jay N, et al. DCR, 51: 829-35, Jun 2008. Goldstone SE, Kawalek AZ, Goldstone RN, et al. Hybrid capture II detection of oncogenic human papillomavirus: a useful tool when evaluating men who have sex with men with atypical squamous cells of undetermined significance on anal cytology. DCR, 51: 1130-36, Jul 2008. SCOTT Q. NGUYEN, M.D. Sur MD, Nguyen SQ, Scordi-Bello I, Hyun JG, Lento PA, Labow DM. Pseudoxanthoma elasticum: a case of total gastrectomy for gastric hemorrhage. The American Surgeon. 2008. 74:361-2. Nguyen SQ, Buch K, Divino CM, Schnur J, Weber K, Katz LB, Reiner MA, Aldoroty RA, Herron DM. Postoperative Pain after Laparoscopic Ventral Hernia Repair. A prospective comparison of fixation methods: sutures vs. tacks. Journal of the Society of Laparoendoscopic Surgeons. 2008. 12:113-6. Mazeh H, Greenstein AJ, Swedish K, Nguyen SQ, Lipskar A, Weber KJ, Chin EH, Divino CM. Laparoscopic and open reversal of Hartmanns Procedure A comparative retrospective analysis. Surgical Endoscopy. 2008. July 17. Telem D, Chin EH, Colon M, Nguyen SQ, Weber K, Divino CM. Minimally invasive surgery for splenic malignancies. Minerva Chir. 2008. 63:529-40. Buch KE, Genovese MY, Conigliaro J, Nguyen SQ, Byrn JC, Novembre CL, Divino CM. Non-physician Practitioners Overall Enhancement to a Surgical Residents Experience. Journal of Surgical Education. 2008. 65:50-3. Greenstein A, Nguyen SQ, Buch K, Chin EH, Weber KJ, Divino CM. Recurrence after Laparoscopic Ventral Hernia Repair: A Prospective pilot study of sutures versus tack fixation. The American Surgeon. 2008. 74:227-31. Tabrizian P, Nguyen SQ, Greenstein A, Rajhbeharrysingh U, Argiriadi P, Barlow M, Chao TE, Divino CM. The Clinical Significance of Adult Intussusception Found by Computed Tomography. Digestive Diseases Week 2008. San Diego, CA. Tabrizian P, Nguyen SQ, Greenstein A, Rajhbeharrysingh U, Divino CM. Management and Treatment of Iliopsoas Abscess. Digestive Diseases Week 2008. San Diego, CA. Nguyen SQ, Sabnis AA, Bonaccorso A, Wong D, Tabrizian P, Salky B. Laparoscopic surgery for Crohns Disease: an experience with more than 300 patients. Accepted to 11th World Congress of Endoscopic Surgery, Sept 2008. Yokohama, Japan. Nguyen SQ, Tabrizian P, Sabnis AA, Herron DM, Kini SU. Laparoscopic sleeve gastrectomy versus adjustable gastric banding for morbid obesity. Perioperative and short-term outcomes. 11th World Congress of Endoscopic Surgery. Sept 2008. Yokohama, Japan. Sabnis AA, Nguyen SQ, Naidu M, Herron DM. Challenging Laparoscopic Hernia Repairs. Clinical Congress of the American College of Surgeons, Oct 2008. San Francisco, CA. Tabrizian P, Nguyen SQ, Divino CM. Laparoscopic Management and Long-term Outcome of Gastrointestinal Stromal Tumors. Clinical Congress of the American College of Surgeons, Oct 2008. San Francisco, CA.
26
2008 Publications
DAVID PERTSEMLIDIS, M.D. Malignant peripheral nerve sheath tumor: an unusual cause of intussusception. Telem DA, Pertsemlidis D. J Gastrointest Surg. 2008 Sep;12(9):1609-11. KAARE WEBER, M.D. Clopidogrel and bleeding after general surgery procedures. Ozao-Choy J, Tammaro Y, Fradis M, Weber K, Divino CM. Am Surg. 2008 Aug;74(8):721-5. Laparoscopic and open reversal of Hartmann's procedure-a comparative retrospective analysis. Mazeh H, Greenstein AJ, Swedish K, Nguyen SQ, Lipskar A, Weber KJ, Chin EH, Divino CM. Surg Endosc. 2008 Jul 17. Postoperative pain after laparoscopic ventral hernia repair: a prospective comparison of sutures versus tacks. Nguyen SQ, Divino CM, Buch KE, Schnur J, Weber KJ, Katz LB, Reiner MA, Aldoroty RA, Herron DM. JSLS. 2008 Apr-Jun 12(2):113-6. Recurrence after laparoscopic ventral hernia repair: a prospective pilot study of suture versus tack fixation. Greenstein AJ, Nguyen SQ, Buch KE, Chin EH, Weber KJ, Divino CM. Am Surg. 2008 Mar;74(3):227-31. Laparoscopic cortical-sparing adrenalectomy for bilateral pheochromocytoma. Chin EH, Baril DT, Weber KJ, Divino CM. Surg Endosc. 2008 Sep;22(9):2075. MINIMALLY INVASIVE AND LAPAROSCOPIC SURGERY BARRY A. SALKY, M.D., CHIEF Hazzan David, Chin Edward, Salky Barry A. Current Surgical Therapy. Laparoscopic Nissen Fundoplication. 9th ed. 1312-1316. 2008. Nguyen SQ, Teitlebaum E, Sabnis AA, Bonaccorso A, Tabrizian P, Salky B. Laparoscopic Surgery for Crohns Disease: An experience with 335 cases. Submitted to Surgical Endoscopy, 2008. Nguyen SQ, Sabnis AA, Bonaccorso A, Tabrizian P, Salky B. Is Fistulous Disease A Contraindication to Laparoscopic Resection in Crohns Disease. Submitted to Journal of Gastrointestinal Surgery. 2008. Salky B, Hazzan D, Chin E. The SAGES Manual of Strategic Decision Making. Laparoscopic Distal Pancreatectomy Without Splenectomy. ed. Carol H Scott Conner. Springer, 2008. pgs 410-13. Nguyen Scott, Salky Barry A. Laparoscopic Sigmoid Resection for Complicated Diverticulitis (Colovaginal Fistula). Video Abstract. SSAT Video Session II: SAGES 2008. February 2008. MICHAEL EDYE, M.D. MRI estimation of total renal volume demonstrates significant association with healthy donor weight. Cohen EI, Kelly SA, Edye M, Mitty HA, Bromberg JS. Eur J Radiol. 2008 Apr 22. DANIEL HERRON, M.D. Herron DM, Birkett DH, Thompson CC, Bessler M, Swanstrom LL. Gastric bypass pouch and stoma reduction using a transoral endscopic anchor placement ssystem: A feasibility study. Surg Endsosc 2008;22:1093-1099. Herron DM, Marohn M, SAGES-MIRA Robotic Surgery Consensus Group. A consensus document on robotic surgery from the SAGES-MIRA Robotic Surgery Consensus Group. Surgical Endoscopy 2008;22(2):313-325. Herron DM. The Surgeons Lounge Column: Weight loss surgery in the renal transplant patient. General Surgery News 2008 January. Herron DM. The Growing Problem of Obesity How do the procedures compare? Audio Digest General Surgery 2008;55:18. (September 21, 2008) Herron DM. The Growing Problem of Obesity Whats new in bariatric surgery? Audio Digest General Surgery 2008;55:18. (September 21, 2008) Herron DM, Fleishman A. Weight Loss Surgery and Pregnancy. Chapter in Handbook of Nutrition and Pregnancy. Lammi-Keefe CJ Ed. Humana Press, 2008, Chapter 6, 81-92. BRIAN JACOB, M.D. Placement of a laparoscopic adjustable gastric band after failed sleeve gastrectomy. Greenstein AJ, Jacob BP. Surg Obes Relat Dis. 2008 Jul-Aug;4(4):556-8. L. BRIAN KATZ, M.D. Postoperative pain after laparoscopic ventral hernia repair: a prospective comparison of sutures versus tacks. Nguyen SQ, Divino CM, Buch KE, Schnur J, Weber KJ, Katz LB, Reiner MA, Aldoroty RA, Herron DM. JSLS. 2008 AprJun;12(2):113-6. MARK REINER, M.D. Postoperative pain after laparoscopic ventral hernia repair: a prospective comparison of sutures versus tacks. Nguyen SQ, Divino CM, Buch KE, Schnur J, Weber KJ, Katz LB, Reiner MA, Aldoroty RA, Herron DM. JSLS. 2008 Apr-Jun;12(2):113-6. ORGAN TRANSPLANTATION JONATHAN S. BROMBERG, M.D., CHIEF T-bet and eomesodermin play critical roles in directing T cell differentiation to Th1 versus Th17. Yang Y, Xu J, Niu Y, Bromberg JS, Ding Y. J Immunol. 2008 Dec 15;181(12):8700-10. De novo autoimmunity after organ transplantation: targets and possible pathways. Boros P, Bromberg JS. Hum Immunol. 2008 Jul;69(7):383-8. MRI estimation of total renal volume demonstrates significant association with healthy donor weight. Cohen EI, Kelly SA, Edye M, Mitty HA, Bromberg JS. Eur J Radiol. 2008 Apr 22. Addition of plasmapheresis decreases the incidence of acute antibody-mediated rejection in sensitized patients with strong donor-specific antibodies. Akalin E, Dinavahi R, Friedlander R, Ames S, de Boccardo G, Sehgal V, Schrppel B, Bhaskaran M, Lerner S, Fotino M, Murphy B, Bromberg JS. Clin J Am Soc Nephrol. 2008 Jul;3(4):1160-7. The sphingosine 1-phosphate receptor 1 causes tissue retention by inhibiting the entry of peripheral tissue T lymphocytes into afferent lymphatics. Ledgerwood LG, Lal G, Zhang N, Garin A, Esses SJ, Ginhoux F, Merad M, Peche H, Lira SA, Ding Y, Yang Y, He X, Schuchman EH, Allende ML, Ochando JC, Bromberg JS. Nat Immunol. 2008 Jan;9(1):42-53. Islet expression of M3 uncovers a key role for chemokines in the development and recruitment of diabetogenic cells in NOD mice. Martin AP, Grisotto MG, Canasto-Chibuque C, Kunkel SL, Bromberg JS, Furtado GC, Lira SA. Diabetes. 2008 Feb;57(2):387-94. Addition of plasmapheresis decreases the incidence of acute antibody-mediated rejection in sensitized patients with strong donor-specific antibodies. Akalin E, Dinavahi R, Friedlander R, Ames S, de Boccardo G, Sehgal V, Schrppel B, Bhaskaran M, Lerner S, Fotino M, Murphy B, Bromberg JS. Clin J Am Soc Nephrol. 2008 Jul;3(4):1160-7. GONZALO RODRIGUEZ-LAIZ, M.D. Rodriguez-Laiz GP: Sharing the Gift of Life. (Editorial) Current Opinion in Organ Transplantation. 13(3):257-258, June 2008. Rodriguez-Laiz GP and Iyer, K: Chronic Allograft Enteropathy in Chronic Allograft Failure: Natural History, Pathogenesis, Diagnosis and Management Ahsan, N. Ed.; Landes Bioscience. Austin, TX, 2008, pp 170-175. ISBN: 978-1-58706-153-0. Grosskreutz C, Gudzowaty O, Shi P, Rodriguez-Laiz GP, Malone A, Isola L: Partial HLA matching and Rh incompatibility resulting in graft versus host reaction and Evans syndrome after liver transplantation. Am J Hematol. 2008 Jul;83(7):599-601. HIROSHI SOGAWA, M.D. Limited efficacy and unacceptable toxicity of cyclophosphamide for the induction of mixed chimerism and renal allograft tolerance in cynomolgus monkeys. Sogawa H, Boskovic S, Nadazdin O, Abrahamian G, Colvin RB, Sachs DH, Cosimi AB, Kawai T. Transplantation. 2008 Aug 27; 86(4):615-9. MARK STURDEVANT, M.D. Technical failure of the pancreas after SPK transplant: are these patients good candidates for later pancreas retransplant? Wang SN, Sturdevant M, Kandaswamy R, Gruessner RG, Sutherland DE, Humar A. Clin Transplant. 2008 Jan-Feb; 22(1):50-4. PLASTIC SURGERY LESTER SILVER, M.D., CHIEF Taub, P., Silver, L., Gooden, C: Use of the Glidescope for Airway Management in Patients with Craniofacial Abnormalities. Pl. Reconst. Surg. Vol 121, #4, April 2008, P237 (e). Emanuel, P., Lin, R., Silver, L., Birge, M., Shim, H., Phelps, R: Dabska Tumor Arising in Lymphangioma Circumsoriptum, Jr. of Cutaneous Path., 2008, 35,65-69. MICHELLE COPELAND, M.D. Copeland, M: Laser Liposculpture for Body Recontouring (Abstract). Presented at the World Association of Laser Therapy Conference, Sun City, South Africa October, 2008. SCOTT AMES, M.D. Addition of plasmapheresis decreases the incidence of acute antibody-mediated rejection in sensitized patients with strong donor-specific antibodies. Akalin E, Dinavahi R, Friedlander R, Ames S, de Boccardo G, Sehgal V, Schrppel B, Bhaskaran M, Lerner S, Fotino M, Murphy B, Bromberg JS. Clin J Am Soc Nephrol. 2008 Jul;3(4):1160-7. SUSAN LERNER, M.D. Lerner SM. Aliment Pharmacol Ther. 2008 Aug 15;28(4):377-84. Epub 2008 May 31. Review. Kidney and pancreas transplantation in type 1 diabetes mellitus. Lerner SM. Mt Sinai J Med. 2008 Aug;75(4):37284.
27
2008 Publications
ADAM R. KOLKER, M.D. Kolker, A.R. Improving aesthetics and safety in abdominoplasty with broad lateral subcostal perforator preservation and contouring with liposuction. Annals of of Plastic Surgery 2008 May; 60(5): 491-7. JAY MEISNER, M.D. Westreich R, Meisner J, Reino A, Lawson W. The use of combined Bernard-Webster and Karapandzic flaps for subtotal lower lip reconstruction. Plastic and Reconstructive Surgery, May 2008: Volume 121(5) 340e-341e. MATTHEW SCHULMAN, M.D. Correction of chest wall deformity after implant-based breast reconstruction using poly-L-lactic acid (Sculptra). Schulman MR, Lipper J, Skolnik RA. Breast J. 2008 JanFeb;14(1):92-6. PETER TAUB, M.D. Lin H, Levine E, Hoffman S, and Taub PJ. Bilateral breast deformity after neonatal tube thoracostomy in fraternal twins. Plastic and Reconstructive Surgery 2008;121(3):140e-141e. Lipper J, Pazkowski J, and Taub PJ. Purtschers Retinopathy as a cause of postoperative blindness. Plastic and Reconstructive Surgery 2008;122(2):68e. Xipoleas G, Levine E, Silver L, Koch RM, Taub PJ. A survey of microvascular protocols for lower extremity free tissue transfer II: postoperative care. Annals of Plastic Surgery 2008 Sep;61(3):280-4. Taub PJ. Evaluation, Management, and Avoidance of Complications in Craniofacial Surgery. In: Craniofacial Surgery. Thaller, Bradley, and Garri, editors. New York: Informa Healthcare, 2008. Taub PJ, Vecchione L, and Losee JE. Lateral Facial Clefts and Macrostomia. In: Comprehensive Cleft Care. Losee and Kirschner, editors. New York: McGraw-Hill, 2008. Electrosurgical excision technique for the treatment of multiple cutaneous lesions in neurofibromatosis type I.Levine SM, Levine E, Taub PJ, Weinberg H. New York University School of Medicine, 2008 Aug;61(8):958-62. SURGICAL INTENSIVE CARE UNIT ERNEST BENJAMIN, M.D., CHIEF Sinus bradycardia associated with daclizumab in liver transplant recipients: report of 3 cases. Bassily-Marcus A, Kohli-Seth R, Leibowitz A, Murgolo V, Oropello J, Manasia A, Benjamin E. Exp Clin Transplant. 2008 Mar;6(1):80-3. ADEL BASSILY-MARCUS, M.D. Successful placement of a right ventricular assist device for treatment of a presumed amniotic fluid embolism. Nagarsheth NP, Pinney S, Bassily-Marcus A, Anyanwu A, Friedman L, Beilin Y. Anesth Analg. 2008 Sep;107(3):962-4. Sinus bradycardia associated with daclizumab in liver transplant recipients: report of 3 cases. Bassily-Marcus A, Kohli-Seth R, Leibowitz A, Murgolo V, Oropello J, Manasia A, Benjamin E. Exp Clin Transplant. 2008 Mar;6(1):80-3. ROOPA KOHLI-SETH, M.D. Sinus bradycardia associated with daclizumab in liver transplant recipients: report of 3 cases. Bassily-Marcus A, Kohli-Seth R, Leibowitz A, Murgolo V, Oropello J, Manasia A, Benjamin E. Exp Clin Transplant. 2008 Mar;6(1):80-3. Llovet JM, Di Bisceglie AM, Bruix J, Kramer BS, Lencioni R, Zhu AX, Sherman M, Schwartz M, Lotze M, Talwalkar J, Gores GJ; Panel of Experts in HCC-Design Clinical Trials. Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst 2008; 100:698-711. Konstadoulakis MM, Roayaie S, Gomatos IP, Labow D, Fiel MI, Miller CM, Schwartz ME. Aggressive surgical resection for hilar cholangiocarcinoma: is it justified? Audit of a single center's experience. Am J Surg 2008; 196:160-169. Dvorchik I, Schwartz M, Fiel MI, Finkelstein SD, Marsh JW. Fractional allelic imbalance could allow for the development of an equitable transplant selection policy for patients with hepatocellular carcinoma. Liver Transpl 2008; 443-450. Killackey MT, Gondolesi GE, Liu LU, Paramesh AS, Thung SN, Suriawinata A, Nguyen E, Roayaie S, Schwartz ME, Emre S, Schiano TD. Effect of ischemia-reperfusion on the incidence of acute cellular rejection and timing of histologic hepatitis C virus recurrence after liver transplantation. Transplant Proc 2008; 40:1504-1510. Mong, P. Petrulio, C., Kaufman, H.L. and Wang, Q. Activation of Rho kinase by TNF-alpha is required for JNK activation in human pulmonary microvascular endothelial cells. J Immunol 180:550-558, 2008. Ugurel, S., Schrama, D., Keller, G., Schadendorf, D., Brocker, E.B., Houben, R., Zapatka, M., Fink, W., Kaufman, H.L., and Becker, J.C. Impact of the CCR5 gene polymorphism on the survival of metastatic melanoma patients receiving immunotherapy. Cancer Immunol Immunother 57:685-691, 2008. Kaufman, H.L., Lenz, H.J., Marshall, J., Singh, S., Garrett, C., Cripps, C., Moore, M., von Mehren, M., Dalfen, R., Heim, W.J., Conry, R., Urba, W., Benson, A. B., DeBenedette, M.A., Yu, M., Caterini, J. Elias, I., and Berinstein, N. Combination chemotherapy and recombinant ALVAC-CEA-B7.1 vaccine in patients with metastatic colorectal cancer: Results of a Phase II multi-institutional trial. Clin Cancer Res14:4843-4849, 2008. Colonic Pseudo-Obstruction. Kohli-Seth R, Martin L, Arora S, Benjamin E. Open Gastroenterology Journal, 2008, 2, 9-10. ANTHONY MANASIA, M.D. Sinus bradycardia associated with daclizumab in liver transplant recipients: report of 3 cases. Bassily-Marcus A, Kohli-Seth R, Leibowitz A, Murgolo V, Oropello J, Manasia A, Benjamin E. Exp Clin Transplant. 2008 Mar;6 (1):80-3. JOHN OROPELLO, M.D. Sinus bradycardia associated with daclizumab in liver transplant recipients: report of 3 cases. Bassily-Marcus A, Kohli-Seth R, Leibowitz A, Murgolo V, Oropello J, Manasia A, Benjamin E. Exp Clin Transplant. 2008 Mar;6(1):80-3. SURGICAL ONCOLOGY MYRON SCHWARTZ, M.D., CHIEF Mazzaferro V, Chun YS, Poon RT, Schwartz ME, Yao FY, Marsh JW, Bhoori S, Lee SG. Liver Transplantation for Hepatocellular Carcinoma. Ann Surg Onc 2008. Konstadoulakis MM, Roayaie S, Gomatos IP, Labow D, Fiel MI, Miller CM, Schwartz ME. Fifteen-year, single-center experience with the surgical management of intrahepatic cholangiocarcinoma: operative results and long-term outcome. Surgery 2008;143:366-74. Roayaie S, Schwartz M. Expansion of criteria for transplanting patients with hepatocellular carcinoma. Liver Transpl 2008; 14:1071-1072. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath I, Hussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J; SHARP Investigators Study Group. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008; 359:378-390. Schwartz M, Dvorchik I, Roayaie S, Isabel Fiel M, Finkelstein S, Wallis Marsh J, Martignetti JA, Llovet JM. Liver transplantation for hepatocellular carcinoma: Extension of indications based on molecular markers. J Hepatol 2008;49:581-8. Schwartz ME, Roayaie S, Konstadoulakis MM, Gomatos IP, Miller CM. The Mount Sinai experience with orthotopic liver transplantation for benign tumors: brief report and literature review: case reports. Transplant Proc 2008; 40:1759-1762. Sarpel U, Bonavia AS, Grucela A, Roayaie S, Schwartz ME, Labow DM. Does Anatomic Versus Nonanatomic Resection Affect Recurrence and Survival in Patients Undergoing Surgery for Colorectal Liver Metastasis? Ann Surg Oncol. 2008 Nov 20. Chiang DY, Villanueva A, Hoshida Y, Peix J, Newell P, Minguez B, LeBlanc AC, Donovan DJ, Thung SN, Sol M, Tovar V, Alsinet C, Ramos AH, Barretina J, Roayaie S, Schwartz M, Waxman S, Bruix J, Mazzaferro V, Ligon AH, Najfeld V, Friedman SL, Sellers WR, Meyerson M, Llovet JM.. Focal gains of VEGFA and Molecular Classification of Hepatocellular Carcinoma. Cancer Research 2008; 68:6779-88. Hoshida Y, Villanueva A, Kobayashi M, Peix J, Chiang D, Camargo A, Gupta S, Moore J, Wrobel MJ, Lerner J, Reich M, Chan J, Ikeda K, Hashimoto M, Watanabe G, Roayaie S, Schwartz M, Thung S, Gabriel S, Mazzaferro V, Bruix J, Friedman SL, Kumada H, Llovet JM, Golub TR. Gene Expression Profiles of Adjacent Liver Predict Outcome in Hepatocellular Carcinoma. N Engl J Med. 2008;359:19952004. Villanueva A, Chiang DY, Newell P, Peix J, Thung S, Alsinet C, Tovar V, Roayaie S, Minguez B, Sole M, Battiston C, Van Laarhoven S, Fiel MI, Di Feo A, Hoshida Y, Yea S, Toffanin S, Ramos A, Martignetti JA, Mazzaferro V, Bruix J, Waxman S, Schwartz M, Meyerson M, Friedman SL, Llovet JM. Role of dual TKI and an mTOR inhibitor in blocking PI3K pathway in HCC. Gastroenterology. 2008;135:197283, 1983.e1-11. SPIROS HIOTIS, M.D. Phase I/II trial of induction chemotherapy followed by concurrent chemoradiotherapy and surgery for locoregionally advanced pancreatic cancer. Marti JL, Hochster HS, Hiotis SP, Donahue B, Ryan T, Newman E. Ann Surg Oncol. 2008 Dec;15(12):3521-31. HOWARD L. KAUFMAN, M.D. Babyatsky M, Lin J, Yio X, Chen A, Zhang J, Zheng Y, Twyman C, Bao X, Schwartz M, Thung S, Werther JL, Itzkowitz S. Trefoil factor-3 expression in human colon cancer liver metastasis. Clinical and Experimental Metastasis 2008; Nov 2. Schwartz M, Weintraub J. Combined transarterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma. Nat Clin Pract Oncol. 2008 Nov;5(11):630-1.
28
2008 Publications
Mori, F., Giannetti, P., Peruzzi, D., Lazzaro, D., Giampaoli, S., Kaufman, H.L., Ciliberto, G., La Monica, N. And Aurisicchio, L. A therapeutic cancer vaccine targeting carcinoembryonic antigen in intestinal carcinomas. 2008 Oct 20. Kim-Schulze, S., Moroziewicz, D., Wainstein, A., Yang, W. C., Elliott, B., Bereta, M., Kim, D.W., Wang, Q. and Kaufman, H.L. Intrarectal vaccination with recombinant vaccinia virus expressing carcinoembryonic antigen (CEA) induces mucosal and systemic immunity and prevents progression of colorectal cancer. J. Immunol 181:81128119, 2008. Kim-Schulze, S., Moroziewicz, D., Wainstein, A., Yang, W. C., Elliott, B., Bereta, M., Kim, D.W., Wang, Q. and Kaufman, H.L. Intrarectal vaccination with recombinant vaccinia virus expressing carcinoembryonic antigen (CEA) induces mucosal and systemic immunity and prevents progression of colorectal cancer. J. Immunol 181:81128119, 2008. Kaufman, H.L., Wadler, S.C., and Antman, K. (eds.) Molecular Targeting in Oncology. The Humana Press, Inc., 2008. Kaufman, H.L. and Wolchok, J. (Eds). Principles of Tumor Immunotherapy. Kluwer-Springer Press., 2008. Perales, M.A., Wolchok, J.D. and Kaufman, H.L. Targeting vaccines for tumor immunotherapy. In Molecular Targeting in Oncology. Eds. KAUFMAN, H.L., Wadler, S.C. and Antman, K. (eds.) The Humana Press, Inc., 2008. Petrulio, C., DeRaffele, G. and Kaufman, H.L. High-dose Interleukin-2. In Principles of Tumor Immunotherapy. Ed. Kaufman, H.L. and Wolchok, J. Kluwer-Springer Press, 2008. Kim-Schulze, S. Ornstein, M. and Kaufman, H.L. Advances in Immune Monitoring Strategies for Cancer Vaccines and Immunotherapy. In Cancer Vaccines and Tumor Immunity. Eds. Orentas, R.J., Johnson, B.D. and Hodge, J.W. John Wiley & Sons, Inc. pp. 273-291, 2008. Wang, Q. and Kaufman, H.L. Poxvirus expression vectors. In Viral Expression Vectors. Ed. Hefferon, K. Research Signpost Transworld Research Network. pp. 267-298, 2008. DANIEL LABOW, M.D. Konstadoulakis MM, Roayaie S, Gomatos IP, Labow D, Fiel MI, Miller CM, Schwartz ME.Aggressive surgical resection for hilar cholangiocarcinoma: is it justified? Audit of a single center's experience. Am J Surg. 2008 Aug;196(2):160-9. Sur MD, Nguyen SQ, Labow DM, Scordi-Bello I, Lento PA, Hyun JG., Pseudoxanthoma elasticum: a case of total gastrectomy for gastric hemorrhage. Am Surg. 2008 Apr;74(4):361-2. Konstadoulakis MM, Roayaie S, Gomatos IP, Labow D, Fiel MI, Miller CM, Schwartz ME. Fifteen-year, single-center experience with the surgical management of intrahepatic cholangiocarcinoma: operative results and long-term outcome Surgery. 2008 Mar;143(3):366-74. Cho, CS, Labow DM, Gonen M, Jarnagin WR, DAngelica M, Blumgart L, DeMatteo, RP, Impact of Extent of Hepatic Resection for Metastatic Neuroendocrine Carcinoma, Cancer. 2008 Jul 1;113(1):126-34. SASAN ROAYAIE, M.D. Does Anatomic Versus Nonanatomic Resection Affect Recurrence and Survival in Patients Undergoing Surgery for Colorectal Liver Metastasis? Sarpel U, Bonavia AS, Grucela A, Roayaie S, Schwartz ME, Labow DM. Ann Surg Oncol. 2008 Nov 20. Multiple inflammatory and serum amyloid A positive telangiectatic hepatic adenomas with glycogenated nuclei arising in a background of nonalcoholic steatohepatitis. Lim KH, Ward SC, Roayaie S, Cohen E, Schwartz M, Fiel MI, Thung SN. Semin Liver Dis. 2008 Nov;28(4):434-9. Pivotal role of mTOR signaling in hepatocellular carcinoma. Villanueva A, Chiang DY, Newell P, Peix J, Thung S, Alsinet C, Tovar V, Roayaie S, Minguez B, Sole M, Battiston C, Van Laarhoven S, Fiel MI, Di Feo A, Hoshida Y, Yea S, Toffanin S, Ramos A, Martignetti JA, Mazzaferro V, Bruix J, Waxman S, Schwartz M, Meyerson M, Friedman SL, Llovet JM. Gastroenterology. 2008 Dec;135(6):1972-83, 1983.e111. Gene expression in fixed tissues and outcome in hepatocellular carcinoma. Hoshida Y, Villanueva A, Kobayashi M, Peix J, Chiang DY, Camargo A, Gupta S, Moore J, Wrobel MJ, Lerner J, Reich M, Chan JA, Glickman JN, Ikeda K, Hashimoto M, Watanabe G, Daidone MG, Roayaie S, Schwartz M, Thung S, Salvesen HB, Gabriel S, Mazzaferro V, Bruix J, Friedman SL, Kumada H, Llovet JM, Golub TR. N Engl J Med. 2008 Nov 6;359(19):1995-2004. Focal gains of VEGFA and molecular classification of hepatocellular carcinoma. Chiang DY, Villanueva A, Hoshida Y, Peix J, Newell P, Minguez B, LeBlanc AC, Donovan DJ, Thung SN, Sol M, Tovar V, Alsinet C, Ramos AH, Barretina J, Roayaie S, Schwartz M, Waxman S, Bruix J, Mazzaferro V, Ligon AH, Najfeld V, Friedman SL, Sellers WR, Meyerson M, Llovet JM. Cancer Res. 2008 Aug 15;68(16):6779-88. Expansion of criteria for transplanting patients with hepatocellular carcinoma. Roayaie S, Schwartz ME. Liver Transpl. 2008 Aug;14(8):1071-2. Liver transplantation for hepatocellular carcinoma: extension of indications based on molecular markers. Schwartz M, Dvorchik I, Roayaie S, Fiel MI, Finkelstein S, Marsh JW, Martignetti JA, Llovet JM. J Hepatol. 2008 Oct;49(4):581-8. Aggressive surgical resection for hilar cholangiocarcinoma: is it justified? Audit of a single center's experience. Konstadoulakis MM, Roayaie S, Gomatos IP, Labow D, Fiel MI, Miller CM, Schwartz ME. Am J Surg. 2008 Aug;196(2):160-9. Multifocal hepatocellular carcinoma and precancerous lesions in a patient with autoimmune hepatitis-related cirrhosis. Ward SC, Deniz K, Roayaie S, Qin L. Semin Liver Dis. 2008 Feb;28(1):123-7. Fifteen-year, single-center experience with the surgical management of intrahepatic cholangiocarcinoma: operative results and long-term outcome. Konstadoulakis MM, Roayaie S, Gomatos IP, Labow D, Fiel MI, Miller CM, Schwartz ME. Surgery. 2008 Mar;143(3):366-74. MICHAIL SHAFIR, M.D. RPR: Prognostic vales of Expression of Vascular Growth Factors in Carcinoid Disease. Shafir. M, Warner. Proceedings of the North American Neuro-Endocrine Tumor Society Symposium, Feb 2008. BREAST SURGERY CHRISTINA WELTZ, M.D. SHARIF ELLOZY, M.D. Disrupted Sleep the Night Before Breast Surgery is Associated with Increased Postoperative Pain. Wright CE, Bovbjerg DH, Montgomery GH, Weltz C, Goldfarb A, Pace B, Silverstein JH. J Pain Symptom Manage. 2008 Aug 22. Incidence and outcome of filter occlusion during carotid artery stent procedure. Maldonado TS, Loh S, Fonseco R, Poblete H, Adelman MA, Cayne NS, Mussa F, Rockman CB, Sadik M, Ellozy S, Faries P. Ann Vasc Surg. 2008 Nov;22(6):756-61. Landis GS, Faries PL. Contemporary Issues in the Management of Carotid Occlusive Disease. Mt Sinai J Med 75:398-400, 2008. Sadek M, Hynecek RL, Goldenberg S, Kent KC, Marin ML, Faries PL. Gene Expression Analysis of a Porcine Native Abdominal Aortic Aneurysm Model. Surgery 144: 252-8, 2008. Anticipatory psychological distress in women scheduled for diagnostic and curative breast cancer surgery. Schnur JB, Montgomery GH, Hallquist MN, Goldfarb AB, Silverstein JH, Weltz CR, Kowalski AV, Bovbjerg DH. Int J Behav Med. 2008 Jan-Mar;15(1):21-8. Hypnosis decreases presurgical distress in excisional breast biopsy patients. Schnur JB, Bovbjerg DH, David D, Tatrow K, Goldfarb AB, Silverstein JH, Weltz CR, Montgomery GH. Anesth Analg. 2008 Feb;106(2):440-4, table of contents. Breast Core Biopsy - A Pathologic-Radiologic Approach. Ira Bleiweiss, MD, Shabnam Jaffer, MD, Susan R. Drossman, MD and Christina Weltz, MD. Elsevier, 2008. VASCULAR SURGERY PETER L. FARIES, M.D., CHIEF DeRubertis BG, Pierce M, Ryer EJ, Trocciola S, Kent KC, Faries PL. Reduced Primary Patency Rate in Diabetic Patients After Percutaneous Intervention Results from more Frequent Presentation with Limb-Threatening Ischemia. J Vasc Surg 47: 101-8, 2008. Lam RC, Rhee SJ, Morrissey NJ, McKinsey JF, Faries PL, Kent KC. Minimally Invasive Retrieval of a Dislodged Wallstent Endoprosthesis After an Endovascular Abdominal Aortic Aneurysm Repair. J Vasc Surg 47: 450-3, 2008. Faries PL, DeRubertis B, Trocciola S, Karwowski J, Kent KC, Chaer RA. Ischemic Preconditioning During the Use of the PercuSurge Occlusion Balloon for Carotid Angioplasty and Stenting. Vascular 16: 1 9, 2008. Sadek M, Hynecek RL, Sambol EB, Ur-Rehman H, Kent KC, Faries PL. Carotid Angioplasty and Stenting: Success Relies on Appropriate Patient Selection. J Vasc Surg 47: 946-51, 2008. Rhee-Moore SJ, DeRubertis BG, Lam RC, Hynecek RL, Lee L, McKinsey JF, Morrissey NJ, Karwowski J, Mureebe L, Kent KC, Faries PL. PeriPeriprocedural Complication Rates are Equivalent Between Symptomatic and Asymptomatic Patients Undergoing Carotid Angioplasty and Stenting. Ann Vasc Surg 22: 233-7, 2008. DeRubertis BG, Vouyouka A, Rhee SJ, Califano J, Karwowski J, Angle N, Faries PL, Kent KC. Percutaneous Intervention for Infrainguinal Occlusive Disease in Women: Equivalent Outcomes Despite Increased Severity of Disease Compared with Men. J Vasc Surg 48: 150-8, 2008. Turnbull IC, Sadek M, Marin ML, Faries PL. Using the CoilTrac Delivery System with the Talent Abdominal Stent Graft: A Single Center Experience Treating Medically HighRisk AAA Patients. Endovasc Today 7: 11-14 (suppl), 2008.
29
2008 Publications
Student perceptions of medical errors: incorporating an explicit professionalism curriculum in the third-year surgery clerkship. Newell P, Harris S, Aufses A Jr, Ellozy S. J Surg Educ. 2008 Mar-Apr;65(2):117-9. Endovascular stent-graft repair of failed endovascular abdominal aortic aneurysm repair. Baril DT, Silverberg D, Ellozy SH, Carroccio A, Jacobs TS, Sachdev U, Teodorescu VJ, Lookstein RA, Marin ML. Ann Vasc Surg. 2008 Jan;22(1):30-6. TIKVA JACOBS, M.D. Endovascular stent-graft repair of failed endovascular abdominal aortic aneurysm repair. Baril DT, Silverberg D, Ellozy SH, Carroccio A, Jacobs TS, Sachdev U, Teodorescu VJ, Lookstein RA, Marin ML. Ann Vasc Surg. 2008 Jan;22(1):30-6. MICHAEL L. MARIN, M.D. Baril DT, Silverberg D, Ellozy SH, Carroccio A, Jacobs TS, Sachdev U, Teodorescu VJ, Lookstein RA, Marin ML. Endovascular stent-graft repair of failed endovascular abdominal aortic aneurysm repair. Ann Vasc Surg. 2008 Jan-Feb;22(1):30-6. Cohen EI, Weinreb DB, Siegelbaum RH, Honig S, Marin M, Weintraub JL, Lookstein RA. Time Resolved MR angiography for the classification of endoleaks after endovascular aneurysm repair. J Magn Reson Imaging. 2008 Mar; 27(3):500-3. Sadek M, Hynecek RL, Goldenberg S, Kent KC, Marin ML, Faries PL. Gene Expression analysis of a porcine native abdominal aortic aneurysm model. Surgery, 2008 Aug; 144(2):252-8. HARRY SCHANZER, M.D. Brachial artery ligation with total graft excision is a safe and effective approach to prosthetic arteriovenous graft infections. Schanzer A, Ciaranello AL, Schanzer H. J Vasc Surg. 2008 Sep;48(3):655-8. Brachial vein transposition arteriovenous fistula: is it an acceptable option for chronic dialysis vascular access? Torina PJ, Westheimer EF, Schanzer HR. J Vasc Access. 2008 Jan-Mar;9(1):39-44. VICTORIA TEODORESCU, M.D. Endovascular stent-graft repair of failed endovascular abdominal aortic aneurysm repair. Baril DT, Silverberg D, Ellozy SH, Carroccio A, Jacobs TS, Sachdev U, Teodorescu VJ, Lookstein RA, Marin ML. Ann Vasc Surg. 2008 Jan;22(1):30-6. ANGELA G. VOUYOUKA, M.D. Brian G. DeRubertis, MD, Angela Vouyouka, MD, Soo J. Rhee, MD, John Karwowski, MD, Niren Angle, MD, Peter L. Faries, MD, K. Craig Kent, MD: Percutaneous Intervention for Infra-inguinal Occlusive Disease in Women: Equivalent Outcomes Despite Increased Severity of Disease Compared to Men . J Vasc Surg. 2008 Jul; 48(1): 150-7.
30
The Ruth J. & Maxwell Hauser and Harriet & Arthur H. Aufses, Jr., M.D.
Department of Surgery
5 East 98th Street, Box 1259 New York, N.Y. 10029 www.mountsinai.org/surgery

2008-2009 Annual Report: "Envisioning Tomorrow's Innovations... "

Transféré par

Informations du document

Description originale:

Titre original

Copyright

Formats disponibles

Partager ce document

Partager ou intégrer le document

Options de partage

Avez-vous trouvé ce document utile ?

Ce contenu est-il inapproprié ?

Droits d'auteur :

Formats disponibles

2008-2009 Annual Report: "Envisioning Tomorrow's Innovations... "

Transféré par

Droits d'auteur :

Formats disponibles

The Ruth J. & Maxwell Hauser and Harriet & Arthur H. Aufses, Jr., M.D.

2008-2009 Annual Report

envisioning tomorrows innovations...

The Mount Sinai Surgery Advisory Board

Letter from the Chairman

2008-2009 Annual Report

The Mount Sinai Hospital 1855

Dr. Arthur H. Aufses

Mount Sinai Department of Surgery

The Mount Sinai Hospital Second Location 1872

Dr. Howard Lilienthal

Dr. Richard Lewisohn

Dr. Leon Ginzburg

Dr. Charles Elsberg

2008-2009 Annual Report

Mount Sinai Department of Surgery

Areas of Growth in the Mount Sinai Department of Surgery

*excludes Affiliate Faculty

2008-2009 Annual Report

Mount Sinai Department of Surgery

2008-2009 Annual Report

Mount Sinai Department of Surgery

Invasive Surgical Innovations

2008-2009 Annual Report

10 Mount Sinai Department of Surgery

2008-2009 Annual Report

I am especially looking forward to working closely with the highly-skilled

Education & Residency

2008-2009 Annual Report

Colon & Rectal Surgery

Division of Colon and Rectal Surgery

Randolph Steinhagen, M.D.

Mount Sinai Department of Surgery

Division of General Surgery

Celia M. Divino, M.D.

2008-2009 Annual Report

Laparoscopic & Minimally Invasive Surgery

Division of Laparoscopic and Minimally Invasive Surgery

Mount Sinai Department of Surgery

Division of Organ Transplantation

Johnathan S. Bromberg, M.D.

2008-2009 Annual Report

Division of Pediatric Surgery

18 Mount Sinai Department of Surgery

Plastic & Reconstructive Surgery

Division of Plastic and Reconstructive Surgery

Lester Silver, M.D.

2008-2009 Annual Report 19

Surgical Intensive Care

Division of Surgical Intensive Care

Mount Sinai Department of Surgery

Division of Surgical Oncology

Myron E. Schwartz, M.D.

2008-2009 Annual Report

Division of Vascular Surgery

Mount Sinai Department of Surgery

2008-2009 Annual Report

Existing Endowed Chairs

Existing Named Fellowships

The Friends of The Mount Sinai Department of Surgery

Mount Sinai Department of Surgery

2008-2009 Annual Report